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2. ABSTRACT 
 
The free radical theory of aging postulates that accumulation of oxidative damage in major 
cellular components is the predominant underlying cause of the aging phenotype. This damage 
is caused most commonly by reactive oxygen species (ROS) and antioxidant enzymes such as the 
superoxide dismutases (SOD) that neutralize ROS, are therefore vital. Manganese superoxide 
dismutase (MnSOD) is particularly critical as it is functional in the mitochondria, a major site for 
ROS generation. Numerous studies have demonstrated a tissue-specific decrease in the activity 
and mRNA levels of major antioxidants, including MnSOD, with aging, however the exact 
mechanism of this regulation is unclear. It was hypothesized that a general down-regulation of 
various antioxidant enzymes such as this may occur at the transcriptional level. In order to 
investigate SOD2 regulation, a comprehensively annotated rat SOD2 promoter region was 
established using the appropriate bioinformatics tools. Following this, SOD2 mRNA levels in 
tissues from young and old rat tissue were compared using quantitative PCR. The results showed 
increased and decreased SOD2 mRNA levels in old compared to young liver tissue and brain 
tissue, respectively, however these trends were not statistically significant. As MnSOD has been 
shown to be epigenetically downregulated in various age-related diseases it was hypothesized 
that the decrease in MnSOD mRNA levels seen in aging brain tissue may be a result of epigenetic 
regulation at the SOD2 (MnSOD gene) promoter, specifically, through DNA methylation. A 
methylation assay assessing the SOD2 gene promoter revealed no significant evidence of 
hypermethylation. Although this suggests that promoter methylation is an unlikely mechanism 
of SOD2 regulation in aging, further work would need to be implemented in order to prove this 
conclusively.  
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3. INTRODUCTION  
 
3.1. AGING, AGE-RELATED DISEASE AND THE FREE RADICAL THEORY 
 
Aging is generally defined as a gradual deterioration of an individual’s overall physiological 
capacity as well as cellular function, such that they are more susceptible to developing a variety 
of illnesses and have reduced probability of survival (D’Aquila et al., 2012). There are a number 
of diseases that show an age-related prevalence, including certain cancers, cardiovascular 
disease, and neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease (Valko et 
al., 2007; Gupta et al., 2014). At the molecular level, aging can be described as the progressive 
accumulation of damage to major cellular components such as nucleic acids, proteins and lipids, 
leading to increased cellular senescence and cell death (Rattan, 2006; Rai & Troen, 2011). There 
is no universally accepted biological theory of aging to date, however a number of partially 
explanatory theories have been put forward. Of these, the free radical theory of aging is possibly 
the most widely accepted and well established.  
 
The free radical theory of aging was first proposed in 1956 by Denham Harman and has since 
gained large traction in the biogerontological community. This theory claims that the aging 
phenotype is related to the accumulation of oxidative damage to various cellular components as 
a result of aerobic metabolism (Wickens, 2001; Liochev, 2013). The damaging species implicated 
in this process are collectively referred to as reactive oxygen species (ROS) and are generated 
predominantly as by-products of the mitochondrial respiratory chain, but can result from 
environmental sources such as ultra violet light, ionizing radiation and some pollutants (Wickens, 
2001). In the electron transfer chain (ETC), oxygen is reduced to water in four sequential steps. It 
is, however, possible for electrons in this chain to be leaked, and react with other intermediates, 
leading to the formation of free radicals and subsequently ROS (Raha & Robinson, 2000; Barja, 
2013). Mitochondria are extremely vulnerable to damage mediated by ROS as they constitute 
the predominant site of oxygen metabolism (Kirkinezos & Moraes, 2001; Barja, 2013). 
Mitochondrial DNA lacks protective histone proteins and is in close proximity to the ETC situated 
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on the inner mitochondrial membrane, making it a major target for oxidative damage. This 
damage is not repaired as efficiently as in nuclear DNA, thus leading to elevated levels of 
mutagenesis (Alexeyev, Doux, & Wilson, 2004; Barja, 2013). In general, oxidative damage to 
mitochondrial DNA as well as lipid peroxidation in the mitochondrial membranes lead to a 
reduction in ATP production and further generation of ROS and cytotoxicity, events that are 
suggested to be fundamental to the aging phenotype (Alexeyev, Doux & Wilson, 2004; Barja, 
2013). 
 
The major free radical implicated in ROS production is the superoxide anion (∙O2-), formed when 
an oxygen molecule accepts an additional electron (Flint, 1993). Superoxide itself can have toxic 
effects, however its more harmful role is in the generation of other ROS. Superoxide reacts with 
hydrogen to form hydrogen peroxide (H2O2) and singlet oxygen (1O2, a non-radical, excited form 
of oxygen) in two separate reactions (Lee, Koo, & Min, 2004). These ROS have been implicated in 
various forms of macromolecular damage and contribute to the production of more toxic ROS 
such as the hydroxyl radical (∙OH) (Lee, Koo & Min, 2004). The hydroxyl radical is highly reactive 
and can cause direct oxidative damage to proteins, lipids and DNA. In DNA, ∙OH can react with 
DNA bases and the deoxyribose backbone leading to mutations and genomic instability (Valko et 
al., 2007; Gupta et al., 2014). In proteins, oxidation of amino acid side chains (particularly of 
methionine and cysteine) can lead to the production of disulphide bonds between thiol groups 
and can also lead to other detrimental effects. Finally, lipid peroxidation can lead to irreversible 
impairment of the phospholipid membrane fluidity and elasticity which can result in rupturing of 
the cell membrane (Wickens, 2001; Matés et al., 2012). Other toxic ROS include peroxyl and 
alkoxyl radicals and peroxynitrate, reactive substances that also play a significant role in oxidative 
damage to cellular macromolecules (Lee, Koo & Min, 2004).  
 
A large body of evidence has demonstrated that cellular levels of these oxidative lesions increase 
with age (Harman, 2006; Lee et al., 2004; Matés, 2000; Raha & Robinson, 2000; Barja, 2013; 
Liochev, 2013). This and other lines of evidence, including studies on correlations of species life 
span, metabolic rate and antioxidant activity as well as life span extension by calorie restriction 
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(which leads to a decline in the production of ROS), contribute convincing evidence in support of 
the free radical theory of aging (Wickens, 2001; Lin et al., 2002; Balaban, Nemoto & Finkel, 2005; 
Hulbert et al., 2007; Barja, 2013; Liochev, 2013).  
 
In addition to the general condition of aging, ROS have been implicated in a number of age-
related diseases, including various sporadic cancers and neurodegenerative conditions (Valko et 
al., 2007; Gupta et al., 2014). Accumulative damage to DNA is now known to be a major cause of 
cancer (Waris & Ahsan, 2006; Matés et al., 2012). As ROS can directly damage DNA it is considered 
both a mutagenic and carcinogenic factor (Loft & Poulsen, 1996). Additionally, ROS accumulates 
with age in a manner that may predispose an individual to late-onset tumourigenesis.  An 
important oxidative DNA lesion is 7,8-dihydro-8-oxoguanine, which leads to G to T transversion 
mutations. This kind of mutation is frequent in various cancers and is the most common mutation 
in the p53 tumour suppressor gene (Hollstein, et al., 1991). This and other damage caused by 
oxidative modifications to DNA (including single and double strand breaks and DNA cross-links) 
can occur in proto-oncogenes and tumour suppressor genes, leading to neoplastic formation 
(Valko et al., 2007). Additionally, ROS have been implicated in signaling pathways central to 
tumourigenesis and various lines of antioxidant defenses, including free radical scavengers, have 
been shown to have aberrant expression patterns in a number of cancers (Valko et al., 2007; 
Gupta et al., 2014).  
 
Based on in vitro and in vivo studies of Alzheimer’s disease (AD), amyotrophic lateral sclerosis 
(ALS), as well as other neurodegenerative conditions, aging and mitochondrially-generated ROS 
accumulation may play a large role in the initiation and progression of these late-onset diseases 
(Reddy, 2009; Sutherland et al., 2013). The brain is particularly vulnerable to oxidative damage 
due to its high oxygen usage, high content of polyunsaturated fatty acids and availability of redox 
metals (Valko et al., 2007). As a consequence of this, neurons are highly sensitive to oxidative 
damage which subsequently leads to neuronal cell death, a unifying mechanism in 
neurodegeneration (Ischiropoulos & Beckman, 2003). The brains of AD patients show a 
significant accumulation of amyloid-β (Aβ) peptide, a major component of aberrant plaques that 
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deposit in vital regions of the brain (Butterfield, et al., 2002; Sutherland et al., 2013). It is 
postulated that Aβ may serve as an antioxidant for brain lipoproteins and increased production 
of Aβ as a result of oxidative stress in aging is a critical event in AD progression (Butterfield, et 
al., 2002; Sutherland et al., 2013). This and other research provides strong evidence for the 
association of aging, oxidative damage and neurodegeneration.  
 
3.2. ANTIOXIDANT DEFENSES IN AGING, CANCER AND 
NEURODEGENERATIVE DISEASE 
 
In order to minimize accumulation of ROS, and the detrimental effects it is associated with, 
aerobic organisms have developed complex defense mechanisms, the forefront of which are the 
antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase 
(CAT) (Lee, Koo & Min, 2004).  CAT is a highly efficient enzyme that converts hydrogen peroxide 
into water and molecular oxygen (Matés, 2000). Together with GSH-Px, which catalyzes the 
reduction of a variety of hydroperoxides using glutathione, CAT neutralizes potentially toxic 
cellular hydrogen peroxide generated by the SOD enzymes (Matés, 2000). Superoxide dismutases 
are specialized in neutralizing superoxide anion radicals by converting them into hydrogen 
peroxide and molecular oxygen (Miao & Clair, 2009). Three SOD enzymes have been 
characterized in mammals thus far: cytosolic copper-zinc superoxide dismutase (Cu/ZnSOD), 
mitochondrial manganese superoxide dismutase (MnSOD) and extracellular superoxide 
dismutase (ECSOD). Of these, MnSOD appears to be the most vital, as demonstrated by early 
lethality of homozygous SOD2 knockout mice, compared to the non-lethal effects of Cu/ZnSOD 
and ECSOD knockouts (Huang et al., 1997). Additionally, mice showing MnSOD deficiency are 
more susceptible to several forms of oxidative stress and cellular senescence (Velarde et al., 
2012) and overexpression of MnSOD in cultured cells renders cells resistant to oxidant-induced 
cytotoxicity and radiation-induced neoplasm (Matés, 2000). As the mitochondria are the 
predominant source of superoxide, and are the organelles most sensitive to its effects, it follows 
that mitochondrial MnSOD is the most critical of the SOD enzymes.  
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The protective effects of the antioxidant enzymes as well as other antioxidant defenses are 
formidable, and minimal steady state levels of ROS are maintained in healthy individuals (Matés, 
2000; Matés et al., 2012). It is when the generation of oxidants exceeds this dynamic defense 
system, that cellular and physiological decline ensues. Naturally, the oxidant/antioxidant balance 
may be perturbed by one of two events: an overall increase in ROS production or a systematic 
decrease in the activity of the cell’s antioxidant armory. With this in mind, as well as the 
significant increase of oxidative damage with aging, and the major role ROS play in various age-
related diseases, it follows that the activity of important antioxidant enzymes has been 
investigated in the context of aging, as well as in disease progression.  
 
The age-related activity of antioxidant enzymes has been assayed in a number of tissues of both 
human and rodents with varying results. Cand and Verdetti (1989) demonstrated that SOD 
activities decrease significantly for the aged liver and kidney in rats. This finding was supported 
by Rao, Xia and Richardson (1990) who found an age-related decrease in SOD activity in rat brain, 
heart, hepatocytes, intestinal mucosa and kidney. A further study by Navarro and Boveris (2004) 
showed a progressive decrease in MnSOD activity in the mitochondria of rat brain and liver. 
Contrary to this Yen et al. (1994) demonstrated an increase in SOD activity in the mitochondria 
of human liver. It is possible that discrepancies in these findings may be due to different technical 
approaches, however a large portion of research to this end suggests that SOD activity does in 
fact decrease in a tissue-specific manner as a function of age, consistent with the age-related 
increase in cellular levels of the superoxide anion radical and the damage it inflicts.  
 
In neurodegenerative studies, superoxide dismutase, catalase and glutathione peroxidase have 
been demonstrated to have reduced activity in brains of AD patients (Marcus et al., 1998). 
Additionally, in mice transgenically expressing hAPP (human amyloid precursor protein), SOD2 is 
found highly expressed around amyloid plaques but is decreased in AD brains overall (Esposito 
et al., 2006). Abnormal SOD2 expression has also been associated with Huntington’s disease, 
where surviving neurons have strongly induced expression of the antioxidant (Ischiropoulos & 
Beckman, 2003). This finding was validated in a study that showed that MnSOD can prevent 
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neural apoptosis and reduce ischemic brain injury (Keller et al., 1998). Downregulation of SOD1, 
the gene encoding for Cu/ZnSOD, in mice and in cells is also associated with increased 
neurodegeneration and neural death. Mutations in the SOD1 gene have been frequently 
detected in ALS and may represent an initiating factor in this disease (Ischiropoulos & Beckman, 
2003). Finally, in cancer, MnSOD has been described as a putative tumour suppressor gene due 
to its demonstrated downregulation in various cancer types (Hitchler et al., 2006; Hodge et al., 
2005; Huang, He & Domann, 1999). These findings suggest that the balance between ROS and 
cellular antioxidant defenses such as the SOD proteins may be crucial in the progression of aging, 
cancer and neurodegeneration.  
  
It appears that decreased activity of major antioxidants may play a significant role in the 
accumulation of oxidative damage in aging and age-related disease. A decrease in enzyme activity 
can be caused by a number of factors at the transcriptional, translational and post-translational 
levels. However, it is probable that this kind of age-related, large-scale down-regulation of key 
antioxidant genes is mediated at the transcriptional level, in a systematic manner. Regulation of 
this description frequently falls under the category of epigenetics.  
 
3.3. EPIGENETIC TRENDS IN AGING, CANCER AND NEURODEGENERATIVE 
DISEASE 
 
“Epigenetics” refers to a form of transcriptional regulation of the genome mediated by 
modifications to the chromatin structure of DNA and histone proteins. These modifications can 
be stable or transient and are heritable through mitosis and sometimes, meiosis (Holliday, 2006). 
The compact organization of chromatin determines the accessibility of gene regions to the 
transcriptional machinery, thereby regulating their activation or repression. Common epigenetic 
mechanisms include DNA methylation, alterations of histone proteins and small non-coding RNAs 
(Holliday, 2006). 
 
DNA methylation involves the covalent attachment of a methyl group to the carbon 5 of a 
cytosine residue positioned in a CpG dinucleotide. CpG dinucleotides are found unevenly 
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distributed across the human genome, however they can be found in regions of high 
concentration, referred to as ‘CpG islands’ (CGIs) (Illingworth & Bird, 2009). CGIs can be found in 
approximately 50% of human genes, located upstream of the gene promoter (Illingworth & Bird, 
2009). Most of the CpG sites dispersed sporadically throughout the genome are highly 
methylated, however, CGIs within gene promoter regions remain largely unmethylated (Klose & 
Bird, 2006). Upon the rare occurrence of promoter CGI methylation, the induction of long term 
transcriptional silencing ensues. DNA methylation can lead to gene repression directly, by 
preventing the binding of transcription factors through steric hindrance, or indirectly, by 
recruiting various methyl-binding domain proteins (MBDs) (Holliday, 2006). MBDs can interact 
with enzymes such as histone deactylases and histone methyltransferases to synergistically 
reconfigure the chromatin structure and promote repression of gene expression (Holliday, 2006).  
 
Global epigenetic patterns are established at the pre-conceptional period and are later 
reprogrammed during embryogenesis and cell differentiation. However, these patterns can 
undergo alterations throughout an organism’s lifetime, in response to exogenous and 
endogenous stimuli (Aquila et al., 2012). In fact, a large body of research has established 
numerous epigenetic patterns that appear to change with age, indicating that epigenetic 
modifications may contribute to or be a result of this phenotype (Aquila et al., 2012; Vlaming & 
Leeuwen; Gentilini & Castaldi, 2012). In general, a progressive loss of total methylated cytosine 
with age has been demonstrated in most vertebrate tissues (Richardson, 2003). This 
hypomethylation is localized mainly in non-island CpGs dispersed over repetitive gene sequences 
(Jintaridth & Mutirangura, 2010). In contrast, during aging, a robust rise in levels of DNA 
methylation at specific gene promoters has been described (Gentilini, et al., 2012; Winnefeld & 
Lyko, 2012). This promoter hypermethylation has been detected in genes for tumour suppression 
(p16INK4A, RASSF1), metabolism (ECRG4, ATP13A4) and DNA repair (MLH1, BRCA1) amongst 
others (Gentilini, et al., 2012; Winnefeld & Lyko, 2012). These findings suggest that there is a loss 
of epigenetic control that accompanies aging. This epigenetic drift may predispose an individual 
to age-related diseases and other detrimental symptoms of aging through the reactivation of 
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potentially mutagenic sequences (e.g., transposons and repetitive sequences) and the 
inactivation of important housekeeping genes (Aquila et al., 2012). 
 
This theory is supported by similar epigenetic changes seen in the epigenomes of cancer patients. 
As in aging, there are two predominant aberrant methylation patterns observed – global DNA 
hypomethylation and promoter-specific hypermethylation (Herman & Baylin, 2003; Ehrlich, 
2002; Soo You & Jones, 2012). In cancer, gene silencing through DNA methylation is a common 
mechanism for the repression of tumour-suppressor genes as well as DNA repair enzymes (Jones 
and Baylin, 2007; Toyota & Issa, 1999; Soo You & Jones, 2012). Conversely, a loss in DNA 
methylation can have equally detrimental effects. Similar to the aged epigenome, global 
hypomethylation may lead to genomic rearrangements caused by expression of repeat 
sequences and reactivation of previously silenced genes and DNA elements (Tsai & Baylin, 2011). 
 
Aberrant epigenetic patterns have also been detected in a number of neurological diseases, 
including Alzheimer’s. The sporadic origin of up to 90% of AD cases, the vast differences in 
individual susceptibility and disease manifestations as well as the age-related onset of the disease 
suggest that environmental and epigenetic mechanisms may play a major role in sporadic AD 
etiology (Zawia, Lahiri & Cardozo-Pelaez, 2009). It has been postulated that epigenetic 
mechanisms promoting the accumulation of oxidative damage in the brain may be a major 
initiating factor in AD. DNA methylation patterns analyzed in prefrontal cortex and lymphocytes 
from late-onset AD patients, revealed age-specific epigenetic drift characterized by unusual 
methylation patterns (Wang, Oelze, & Schumacher, 2008). Specifically, promoter 
hypomethylation of genes associated with AD, such as the beta-amyloid precursor protein (APP) 
may lead to the increased levels of APP and Aβ and subsequent ROS production seen in AD brains. 
Conversely, other AD-associated genes appear to be repressed late in life, suggesting that 
promoter hypermethylation may contribute to AD (Zawia et al., 2009).   
 
The similarities in patterns of epigenetic change seen in aging and cancer and the age-related 
epigenetic drift seen in AD may provide insight into the mechanism through which aging confers 
an increased risk for age-related disease progression. Analysis of the promoter methylation of a 
21 
 
number of tumour-suppressor and tumour-related genes from non-cancerous autopsy samples 
has revealed that methylation occurs in these genes in an age-related and tissue specific manner, 
suggesting that age-related methylation may constitute a mutator process (Waki, Tamura, Sato, 
& Motoyama, 2003). As mentioned, the accumulation of ROS is a phenomenon seen in aging and 
age-related disease and may be a result of the progressive down-regulation of various 
antioxidant enzymes. In theory, it is possible that this down-regulation is due to aberrant 
epigenetic patterns, specifically, repressive epigenetic modifications at gene promoters. This 
would result in an age-related accumulation of ROS, which in turn, renders an individual 
particularly vulnerable to age-related disease. Indeed, aberrant epigenetic regulation of MnSOD, 
the most vital of the superoxide dismutases and antioxidant enzymes, has been demonstrated in 
various age-related diseases. 
 
3.4. EPIGENETIC REGULATION OF MNSOD IN DISEASE 
 
The complete genomic structure for SOD2 has been determined for the human (Wan et al., 1994), 
rat (Ho, Howard & Crapo, 1991) and mouse (Jones et al., 1995) with all of these species showing 
marked conservation of structure and sequence. The SOD2 gene promoter does not contain TATA 
or CAAT boxes but does include GC-rich motifs, promoter properties that are characteristic of 
housekeeping genes. The GC-rich motifs are contained within a large CpG island (approximately 
3.5 kb in length) that spans the promoter and extends into intron two (Wan et al., 1994; Ho, 
Howard & Crapo, 1991; Jones et al., 1995). This region appears to be highly conserved across 
mouse, rat and human (Wan et al., 1994; Ho, Howard & Crapo, 1991; Jones et al., 1995). A 
promoter fragment 500 bp upstream of the transcription start site of the human SOD2 gene has 
been identified as the most critical for basal transcription levels of SOD2 and contains multiple 
putative binding-sites for transcription factors Sp1 (specificity factor 1) and AP-2 (activating 
protein 2) (Xu, Porntadavity & St Clair, 2002).  
 
In addition to the 5’ basal promoter region, an inducible enhancer region has been localized to a 
260 bp fragment in intron two in both the rat and human genes (Rogers et al., 2000). The intronic 
enhancer contains binding sites for NF-кB, C/EBP and NF-1 and possesses the ability to promote 
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cytokine-inducible transcription independent of a promoter sequence (Rogers et al., 2000). It is 
through this enhancer that Mn-SOD expression is dramatically regulated by numerous 
proinflammatory mediators, including tumor necrosis factor-A and interleukin-1 (Kuo et al., 
1999).  
 
Interestingly, the consensus binding sequences for both Sp1 and AP-2 are GC-rich and 
methylation of one or more of these sites has been shown to be responsible for the reduced 
levels of SOD2 in cancer (Hodge et al., 2005; Hitchler et al., 2006). Additionally, the NF-кB and 
NF-1 binding sites located within the SOD2 intronic enhancer both contain a GC-dinucleotide and 
aberrant methylation associated with reduced SOD2 levels has also been found in this region in 
pulmonary arterial hypertension and cancer (Archer et al., 2010; Huang, He & Domann, 1999). 
Additionally, Thaler et al. (2009) showed that diet has an impact on promoter methylation of 
MnSOD.  
 
The discovery that SOD2 may undergo epigenetic regulation in the progression of lifestyle 
diseases such as cancer and hypertension and in response to diet, suggests that epigenetic 
modification may underlie the age-related decrease in activity of MnSOD demonstrated in a 
number of studies (Cand & Verdetti, 1989; Rao, Xia and Richardson, 1990; Navarro and Boveris, 
2004). As  mentioned, hypermethylation of various genes for tumour suppression, metabolism 
and DNA repair have been demonstrated in aging (D’Aquila et al., 2012), suggesting that 
epigenetic downregulation of key housekeeping genes may be a general trend in the aging 
phenotype and may contribute to the an individual’s susceptibility to age-related diseases such 
as cancer and neurodegeneration. To date, the epigenetic regulation of MnSOD has not been 
explored in the context of aging.  
 
This leads to the hypothesis that the decreased activity of SOD2 seen in aging and age-related 
disease is due to epigenetic downregulation of the SOD2 gene through promoter CpG 
hypermethylation. 
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4. SIGNIFICANCE OF THIS WORK  
 
This research will address a novel aspect of the free radical theory of aging, epigenetic down-
regulation of antioxidant genes, as well as improve our understanding of an individual’s 
susceptibility to aging and age-related disease. Additionally, novel markers of this susceptibility 
may be elucidated, which could create opportunity for early detection of disease risk (e.g. in 
breast cancer and Alzhiemer’s disease) as well as for therapy aimed at altering the reversible 
state of aberrant epigenetic modifications. 
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5. HYPOTHESIS, AIM AND OBJECTIVES 
 
5.1. HYPOTHESIS 
 
It is hypothesized that the expression of SOD2 is downregulated as a function of age in rat brain 
and liver tissue and this downregulation is facilitated by the epigenetic mechanism of promoter 
hypermethylation. 
 
5.2. AIM AND OBJECTIVES 
 
This project aims to investigate the epigenetic regulation of the SOD2 gene with age.  
 
Objective 1. Investigate the putative transcriptional and epigenetic regulatory sites in the rat 
SOD2 gene promoter using appropriate bioinformatics tools.  
Objective 2. Quantify and compare levels of SOD2 mRNA in extracts from young and old rat brain 
and liver tissue. 
Objective 3. Quantify and compare promoter methylation of the SOD2 gene in extracts from 
young and old rat brain tissue. 
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6. MATERIALS AND METHODS 
 
6.1.  SOD2 PROMOTER ANNOTATION 
 
6.1.1. Basic SOD2 gene annotation 
 
The rat manganese superoxide dismutase gene promoter from the RGSC 5.0/rn5 Assembly, 
chr1:51,827,380-51,834,232, was investigated using the UCSC genome browser 
(https://genome.ucsc.edu/) and the WashU EpiGenome Browser 
(http://epigenomegateway.wustl.edu/browser/). Both sites generate results illustrating the 
genes position relative to the chromosome, exonic and intronic structure, GC frequency and the 
presence of CGIs and these results were compared for consistency. 
 
6.1.2. PATCH analysis 
 
In order to explore possible regulatory sites located within the rat SOD2 gene promoter a 
predictive transcriptional regulatory site analysis was performed using PATCH, a Gene-Regulation 
tool, (http://www.gene-regulation.com/pub/programs.html#patch). PATCH is a pattern-based 
program for predicting transcription factor binding sites (TFBS) in DNA sequences. PATCH makes 
use of TRANSFAC (developed by the former German National Research Centre for 
Biotechnology), a database that contains information on eukaryotic transcription factors, their 
genomic binding sites and DNA binding profiles. The gene sequence used in this analysis was 
obtained from the UCSC genome browser, RGSC 5.0/rn5 Assembly, chr1:51,827,380-51,834,232.  
 
6.1.3.   Comprehensive SOD2 promoter annotation 
 
In addition to these analyses, which were mapped to the rat SOD2 promoter sequence using 
LaserGene SeqBuilder (www.dnastar.com), a manual comparison of the rat and annotated human 
and mouse SOD2 sequences was performed using the consensus sequences for binding of Sp1, 
AP-2 and other transcription factors as well as experimental data reporting putative protein 
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binding sites based on DNAse I-Hypersensitive site analysis (Kuo et al., 1999). These results were 
coupled with those generated by the UCSC genome browser, WashU EpiGenome Browser and 
the PATCH analysis to delineate the putative transcriptional and epigenetic regulatory sites in the 
rat SOD2 gene promoter. This putative annotation of the rat SOD2 promoter region allowed for 
the elucidation of promoter elements that may be affected by abnormal methylation and that 
could be targeted in a methylation assay.  
 
6.2. REVERSE TRANSCRIPTION QUANTITATIVE PCR (RT-PCR) 
 
Quantitative PCR allows researchers to monitor the amplification of nucleic acid indirectly 
through the quantification of fluorescence (Roche Lightcycler® Real-Time PCR Systems 
Application Manual). SYBR Green I, a molecule that becomes incorporated by double-stranded 
DNA and subsequently fluorescence is a commonly used in this technique (Roche Lightcycler® 
Real-Time PCR Systems Application Manual). The incorporation and fluorescence of SYBR Green 
I in solution increases proportionally as the amount of double-stranded DNA increases through 
consecutive rounds of PCR amplification. By plotting this accumulative fluorescence data against 
the number of PCR cycles (an amplification curve), it is possible to elucidate the cycle at which 
fluorescence of target DNA rises above baseline fluorescence, or the crossing point (CP). The CP 
of a target molecule is dependent on the initial concentration of DNA that was present in solution 
(this relationship is inversely proportional), and can therefore be used to quantify the amount of 
nucleic acid in a sample (Roche Lightcycler® Real-Time PCR Systems Application Manual). In order 
to quantify subtle changes in nucleic acid between samples, it is recommended that relative 
quantification is performed, where the initial concentration of nucleic acid in a sample is not 
quantified absolutely, but in relation to the initial concentration of other reference nucleic acid 
targets (Roche Lightcycler® Real-Time PCR Systems Application Manual).  
 
6.2.1. Primer design 
 
All primer sets synthesized for use in RT-PCR were designed with PrimerBlast 
(www.ncbi.nlm.nih.gov/tools/primer-blast/) and met the following specifications; amplicons 
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were 80 – 200 bp and spanned an exon/intron boundary, primers were between 18 and 22 bp in 
length, GC content fell within the range of 50 – 60 %, annealing temperatures fell within the range 
of 55 – 65 ˚C and self-complementarity and secondary structure of primers was not significant. 
Primers were also assessed for specificity using a NCBI BLAST analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The primer set targeting rat SOD2 mRNA was based on 
the NCBI sequence NM_017051.2.  Additionally, primers were designed for rat RAB11B 
(NM_032617.2), RPN1 (NM_013067.1) and CCT4 (NM_182814.2), three reference genes selected 
using RefGenes from from Genevestigator (http://refgenes.org/). Refgenes is an online 
application that allows users to search for reference genes that are constitutively expressed 
across a chosen set of samples (including organism, tissue and genetic and physiological 
characteristics) based on microarray data. Additionally, reference genes chosen show similar 
expression profiles to the target gene across samples, an important consideration in RT-PCR. The 
validity of these assumptions was assessed by the reproducibility of the RT-PCR data gathered 
for all reference genes as well as by the precision of the inter-assay results.  
Primers were synthesized by Inqaba Biotech and were isolated using Reverse-phase cartridge 
purification. Forward and reverse primer sequences for SOD2, RAB11B, RPN1 and CCT4 are 
shown below.  
 
Table 1. Primer sequences used in RT-PCR. 
Gene Name Primer sequences Amplicon size (bp) 
SOD2 Forward: 5’- CCCAAAGGAGAGTTGCTGGAG -3’ 
Reverse: 5’- CTGTAAGCGACCTTGCTCCT -3’ 
144 
CCT4 Forward: 5’- ATGTCCGAAAGGGTGGGATCT -3’ 
Reverse: 5’- CTCCGCACAGTTTCAGTTGC -3’ 
103 
RAB11B Forward: 5’- ATTCAGGTGGACGGCAAGAC -3’ 
Reverse: 5’- CGGTAGTACGCAGAGGTAATGG -3’ 
89 
RPN1 Forward: 5’- GAAGGGGAAAAGTGGGAGGT -3’ 
Reverse: 5’- GTCGGGTATGGATGAAGCACA -3’ 
117 
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6.2.2. RNA extraction 
 
3 young (1 to 2 months) and 3 old (15 to 19 months) healthy Sprague-Dawley rats were provided 
by WITS Central Animal Service and were euthanized with pentobarbitone. This was in 
accordance with the ethical clearance certificate 2014/33/O issued by the Animal Ethics 
Screening Committee (June 2014). Pentobarbitone overdose was chosen instead of the more 
common CO2-induced euthanasia as the specific oxygen environment of the cell has biological 
influences on SOD2 expression (Dioum et al., 2009). Pentobarbitone is a barbiturate that 
interferes with neurotransmitter receptor signalling in the central nervous system, and does not 
significantly affect SOD2 expression (Bette et al., 2004). The old rats were designated rat A, C and 
D and the young rats were designated rat B, E and F. Snap frozen tissue was stored at – 80 ˚C for 
a period of up to 12 months. Prior to RNA extraction tissues were homogenized using Zymo 
Research’s BashingBead™ Lysis Tubes in a guanidine thiocyanate and β-mercaptoethanol-
containing RNA Lysis Buffer (provided with below mentioned kits). Total RNA was extracted from 
fresh or snap frozen young and old rat brain and liver tissue using Promega’s SV Total RNA 
Isolation System and/or Macherey-Nagel’s NucleoSpin® RNA isolation kit, according to 
manufacturer’s instructions. The amount of tissue processed in each reaction was standardized 
to 30 mg for liver tissue and 60 mg for brain tissue and an average of two RNA samples were 
extracted from each rat for each tissue (liver and brain). Prior to RNA elution each spin column 
was incubated with a solution of DNAse I (Cat.# Z3105) and 0.09M MnCl2 to degrade 
contaminating genomic DNA. RNA was eluted and stored in nuclease-free water at – 80 ˚C. RNA 
eluents were quantified and assessed for purity using a NanoDrop-1000 spectrophotometer by 
ensuring that the 280/260 and 230/260 ratios fell within the acceptable range of 1.8 to 2.2. 
Furthermore, before use in cDNA synthesis, all RNA eluents were assessed using agarose gel 
electrophoresis and the Bio-Rad Gel Doc XR System with Image Lab™ Software to confirm the 
absence of significant degradation. RNA was resolved with the Fermentas GeneRuler 1kB 
(molecular weight range 250 bp to 10000 bp) for 20 minutes at 100 V on a 10 % agarose gel 
(prepared with GRGreen nucleic acid stain) in a TAE buffer system. 
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6.2.3. Reverse transcription 
 
RNA was converted into cDNA using the RevertAid First Strand cDNA Synthesis kit (Thermo 
Scientific), according to manufacturer’s instructions. Input RNA was standardized to a 
concentration of 100 ng/µl of total reaction mix (20 µl) and an Oligo(dT)18 priming strategy was 
used. This kit makes use of the RevertAid M-MuLV Reverse Transcriptase which has relatively low 
RNAse H acitivity and the RiboLock™ RNAse Inhibitor which effectively protects RNA from 
degradation. The reaction mix was incubated at 42 ˚C for 60 minutes during cDNA synthesis and 
then at 70 ˚C for 5 minutes for reaction termination. cDNA synthesis was performed using two 
separate RNA samples from each rat, for brain tissue and one RNA sample from each rat, for liver 
tissue. 
6.2.4. Quantitative PCR 
 
cDNA used in all quantitative PCR reactions was synthesized no more than 4 hours prior to RT-
PCR. The standard reaction used in all the RT-PCR performed was as follows; 2X Maxima SYBR 
Green qPCR Master Mix (Thermo Scientific), 0.3 µM reverse and forward primer, 100 ng cDNA 
and nuclease-free water made up to 25 µl. The master mix is comprised of Maxima Hot Start Taq 
DNA Polymerase, Maxima SYBR Green qPCR Buffer (with KCL, (NH4)2SO4 and optimized MgCl2 
concentration), SYBR Green I and dUTP.  Reactions were loaded into white Thermo-Fast® 96 well, 
low profile plates (Thermo Scientific) and the plates were sealed with optically clear adhesive 
seals (Thermo Scientific). All RT-PCR experiments were performed on the Roche LightCycler® 480 
Instrument with software version 1.0.  
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Melting curve analysis 
During melting curve analysis, the fluorescence of the sample is monitored while the 
temperature is steadily increased (up to 95 ˚C) and is then dropped to 60 ˚C and increased to 95 
˚C once again. During the initial temperature increase the double-stranded DNA becomes single-
stranded and the fluorescence decreases as SYBR green I is released. As the temperature 
decreases, the fluorescence increases once again and eventually peaks at the primer set’s ideal 
annealing temperature. The resulting curve is converted to a first derivative plot of fluorescence 
as a function of time. Specificity of each primer set is illustrated by a single peak on the melting 
curve. Additional informative characteristics of the melting curve are the height and width of the 
peak. A relatively short peak is representative of “late amplification” of the target and may 
indicate a low efficiency of amplification, while a relatively wide peak can mask the presence of 
more than one specific target and should be further investigated. In order to evaluate the 
specificity of each primer set, melting curve analyses were performed in replicate or triplicate 
under the following conditions;  
 
Table 2. PCR cycling conditions for melting curve analysis. 
Step Temperature (˚C) Duration (s) Number of cycles 
Initial denaturation 95 600 1 
Denaturation 95 15 40 
Annealing 60 30 40 
Extension  72 30 40 
Melt 95 5 1 
 60 30 1 
 95 5 1 
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The cDNA used in these experiments was synthesized from RNA originating from rat A. The 
resulting curves were converted to first derivative plots (-dF/dT plotted as a function of T) using 
a Tm Calling analysis and the melting curves were assessed.  
 
Standard curve analysis 
Standard curves are establishing by determining the CP values of a series of template dilutions. 
These values are then plotted against the log concentration of the template, generating a linear 
curve. The gradient of this curve is indicative of the PCR efficiency, where the theoretical 
efficiency maximum of 2 indicates that the amount of product doubles with each cycle (Bustin et 
al., 2009). By using a broad range of template dilutions (at least 3 orders of magnitude) the 
sensitivity and limit of detection can also be assessed. Finally, by performing the PCR in replicate, 
the precision of the standard curve can be determined (Roche Lightcycler® Real-Time PCR 
Systems Application Manual).  
 
The cDNA used in these experiments was synthesized from RNA originating from rat A. Five 
standard concentrations of cDNA were prepared through serial dilution, each differing by one 
order of magnitude and together covering a range of approximately 0.01 ng/µl to 100 ng/µl. RT-
PCR at each concentration with each primer set was run in triplicate and a calibration curve was 
created by plotting the average CP (crossing point) versus the order of magnitude using Excel. 
The average efficiency of each target or reference gene amplification was calculated using the 
calibration curve gradient and the standard formula E = 10-1/slope. Additionally the correlation 
coefficient was calculated to assess the linear relationship between CP values and the decreasing 
order of magnitude. The RT-PCR parameters for these reactions and all subsequent reactions 
were as follows; 
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Table 3. Standard RT-PCR cycling conditions. 
Step Temperature (˚C) Duration (s) Number of cycles 
Initial denaturation 95 600 1 
Denaturation 95 15 40 
Annealing 60 30 40 
Extension  72 30 40 
 
Data normalization 
In order to establish the unknown relative concentration of SOD2 cDNA in samples generated 
from RNA samples (originating from liver and brain tissue of three old and three young rats) RT-
PCR reactions for SOD2 and three reference genes were run in triplicate. Additionally, for each 
primer set and sample used, a no reverse transcriptase control (NRTC) and a no template control 
(NTC) was included to assess for the presence of non-specific signalling resulting from genomic 
DNA amplification or background signalling. A “young” tissue sample was selected for calibration 
in each category. As mentioned, relative quantification compares the mRNA levels of the target 
sequence to the reference sequences in a single sample (Roche Lightcycler® Real-Time PCR 
Systems Application Manual). The final result is expressed as a ratio that is meaningful only when 
compared between samples. Another level of normalization is necessary between samples and 
is usually implemented by designating one of the samples a ‘calibrator sample’. All other samples 
are compared to the calibrator sample to account for sample variability.  
 
 
 
 
Using the CP values generated by these experiments as well as the efficiency values obtained 
from the standard curves of SOD2 and the three reference genes, the relative normalized ratio 
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of SOD2 in each sample was calculated according to the following formula (Roche Lightcycler® 
Real-Time PCR Systems Application Manual); 
 
Normalized relative ratio = Et CP (target) calibrator – CP (target) sample / Er CP (reference) calibrator – CP (reference) sample 
 
Where Et is the efficiency of SOD2 amplification, and Er is the average efficiency of RAB11, RPN1 
and CCT4 amplification. 
 
A total of three relative ratios each were obtained for samples derived from old rat liver tissue 
and young rat liver tissue and six relative ratios each were obtained for samples derived from old 
rat brain tissue and young rat brain tissue. The relative ratios were averaged for each category 
and the standard deviation (SD) was calculated using Excel. Based on the standard deviation, the 
standard error (SE) for each category was calculated with the following formula; 
 
SE = SD 
        √n 
Where n is the sample size. 
 
The average relative ratios for each group (young rat liver tissue, old rat liver tissue, young rat 
brain tissue and old rat brain tissue) was plotted in a histogram using Excel, with SE bars included.  
 
Statistical analysis 
To assess whether the difference between the relative SOD2 ratios in young and old rat tissue 
was statistically significant, t-tests assuming equal variance and a value of alpha = 0.05 were used. 
The t-tests were performed using the Excel data analysis tool.  
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6.3. BISULFITE DNA CONVERSION AND METHYLATION-SPECIFIC PCR 
 
Due to the rapid development of the field of epigenetics in recent years, the establishment of 
reliable assays that are used to monitor changes in the epigenetic environment has become of 
utmost importance (DeAngelis & Farrington, 2008). Although many techniques are now available 
to analyze changes in DNA methylation patterns, bisulfite modification of DNA still forms the 
foundation upon which most of these techniques are based (DeAngelis & Farrington, 2008).  
 
6.3.1. Primer design 
 
All primer sets synthesized for use in methylation-specific PCR were designed with Zymo 
Research’s Bisulfite Primer Seeker (www.zymoresearch.com/tools/bisulfite-primer-seeker) and 
met the following specifications; amplicons were 80 - 200 bp in length and contained 4 to 8 CpG 
dinucleotides, primers contained not more than one CpG dinucleotide and several non-CpG 
cytosine residues. Primers were designed to target the SOD2 promoter region -300 bp upstream 
to +120 bp downstream of the transcription start site within the gene CpG island, based on the 
NCBI Gene ID: 24787. Primer sets were synthesized by Inqaba Biotech and were isolated using 
Reverse-phase cartridge purification. The sequences for two different primer sets targeting two 
separate promoter regions (designated region 1A and region 1D) are listed below; 
 
Table 4. Primer sequences used in MS-PCR. 
Gene Name Primer sequences Amplicon size (bp) 
Promoter 
region 1A 
Forward: 5’- AGAAGAGGYGGGGTTTAGTTTGAGGGTG -3’ 
Reverse: 5’- AACAAAACRACACACAAAAAAAACC -3’ 
180 
Promoter 
region 1D 
Forward: 5’- GGGTTAGYGTTTAGTTGTGTTTTTG -3’ 
Reverse: 5’- ACCCCRAACCCTACCACTTACCTACAC -3’ 
159 
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Region 1A is located approximately -283 to -103 bp relative to the SOD2 transcription start site 
and region 1D is located approximately -47 bp to 112 + bp relative to the transcription start site.  
 
6.3.2. Genomic DNA extraction 
 
Whole genomic DNA was extracted from snap frozen brain tissue (previously described) using 
the NucleoSpin® Tissue from Macherey-Nagel, according to manufacturer’s instructions. The 
amount of tissue processed in each reaction was standardized to 60 mg. DNA quality was 
assessed using gel electrophoresis and the Bio-Rad Gel Doc XR System with Image Lab™ Software. 
DNA was resolved with the Fermentas GeneRuler 1kB (molecular weight range 250 bp to 10000 
bp) for 45 minutes at 100 V on a 10 % agarose gel (prepared with GRGreen nucleic acid stain) in 
a TAE buffer system. Additionally, DNA quantity and purity was evaluated using a NanoDrop-1000 
spectrophotometer by ensuring that the 280/260 and 230/260 ratios fell within the acceptable 
range of 1.8 to 2.2. 
 
 
6.3.3. Bisulfite conversion 
 
This experiment made use of the EZ DNA Methylation-Startup™ Kit (Zymo research). This 
required approximately 200 ng of extracted DNA to be made up to a volume of 20 µl with 
nuclease-free water. This solution was then incubated at 98 ˚C for 8 minutes and at 64 ˚C for 3.5 
hours with the bisulfite-containing Conversion Reagent. Bisulfite induces the conversion of all 
unmethylated cytosines into uracil, while methylated cytosines remain unchanged. After 
incubation, DNA was isolated through a NucleoSpin® Tissue Column, washed, desulphonated and 
eluted in slightly alkaline buffer.  
 
6.3.4. Methylation-specific PCR 
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Methylation-specific PCR (MS-PCR) was carried out using two primer sets targeting the rat SOD2 
promoter and bisulfite-converted DNA derived from each rat. Each MS-PCR reaction used 
ZymoTaq™ PreMix, 0.3 µM forward and reverse primers, approximately 50 ng of bisulfite 
converted DNA and nuclease-free water. ZymoTaq™ PreMix contains a hot start DNA polymerase 
specifically designed for the amplification of bisulfite-treated DNA (which can be fragmented and 
somewhat degraded) as well as a reaction buffer and dNTP mix. The PCR conditions for both 
primer sets used are tabulated below; 
 
Table 5. MS-PCR cycling conditions. 
Step Temperature (˚C) Duration (s) Number of cycles 
Initial denaturation 95 120 1 
Denaturation 95 30 35 
Annealing 50 30 35 
Extension  72 40 35 
Final extension 72 120 1 
 
The successful amplification of each DNA target was confirmed with gel electrophoresis.  
 
6.3.5. DNA cloning 
 
Plasmid ligation 
The DNA amplicons generated through MS-PCR were purified using the GeneJET PCR Purification 
Kit (Thermo Scientific), according to manufacturer’s instructions. Following purification, DNA 
amplicons were ligated into the pGEM®-T Easy Vector (according to manufacturer’s instructions) 
in a 1:3 ratio of vector to insert with T4 DNA Ligase, Rapid Ligation Buffer (Promega) and nuclease-
free water. The solution was incubated for 1 to 3 hours at room temperature. 
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Bacterial transformation 
The ligation mix was then incubated with JM109 Mix & Go Z-Competent™ E. coli Cells (Zymo 
Research), in a ratio of not more than 10 % of the final solution and streak plated onto LB agar 
plates that had been supplemented with 100 µg/ml Ampicillin, 0.1 mM IPTG and 0.003 % X-gal in 
DMF. The plates were incubated at 37 ˚C overnight, after which 2 to 3 white colonies from each 
transformation were selected for overnight liquid culture. 
 
Plasmid purification and digestion 
Plasmid DNA was isolated from the bacterial culture using the GeneJET Plasmid Miniprep Kit 
(Thermo Scientific) and quantified on a NanoDrop-1000 spectrophotometer. To ensure that each 
plasmid isolation contained the expected insert, plasmids were incubated with the EcoRI 
digestive enzyme and buffer (Thermo Scientific) for 1.5 hours. Digestion with EcoRI effectively 
excises the insert, creating two separate fragments that can be assessed for bp length using gel 
electrophoresis.  
 
6.3.6. Sequencing and analysis 
 
DNA fragments were sequenced by Inqaba Biotech using an ABI 3130XL sequencer and the 
Geospiza Finch Suite. Sequences were analyzed using FinchTV and then aligned to the expected 
target sequences using EMBOSS Needle (http://www.ebi.ac.uk/Tools/psa/emboss_needle/). For 
each category (young brain tissue and old brain tissue), 3 biological and 3 technical repeats were 
sequenced. The level of methylation in each DNA fragment sequenced was quantified as the 
amount of unconverted cytosine found in the final DNA product. The level of methylation of the 
two SOD2 promoter regions was compared between brain tissue of young and old rats. 
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7. RESULTS 
 
7.1. GENE ANNOTATION ELUCIDATES THE PUTATIVE TRANSCRIPTIONAL 
AND EPIGENETIC REGULATORY SITES IN THE RAT SOD2 GENE 
PROMOTER 
 
7.1.1. Basic SOD2 gene annotation illustrating conservation and GC 
frequency 
 
The UCSC genome and WashU EpiGenome browsers revealed similar annotations for the rat 
SOD2 gene. The gene is located on chromosome 1, band q11. It consists of 5 exons and 4 introns 
and shows high levels of conservation across species in all exonic regions (Figure 1). Another 
highly conserved region is the CpG island that spans the upstream promoter region and continues 
into intron 2. (Figure 1). It follows that this region shows significantly high GC content. An 
enlarged version of Figure 1 can be found in appendix A (Figure A1).  
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Figure 1. Rat SOD2 promoter annotation illustrating species conservation and GC frequency. A) 
A region of the rat SOD2 gene as illustrated by the UCSC Genome Browser. The image depicts 
the gene CpG island shown as a green band, as well as exon 1 and 2. Other features illustrated 
are the high GC content and the high sequence conservation across 5 species. B) The complete 
rat SOD2 gene as illustrated by the WashU EpiGenome Browser. The gene is shown in the 3’ to 
5’ direction. The CpG is shown as a green band, exons are shown as blue bands.  
 
 
7.1.2. PATCH analysis reveals putative transcriptional binding sites in 
the SOD2 promoter 
 
The PATCH analysis results generated for the 3’ promoter region of the rat SOD2 gene 
corroborated with the published annotations of the SOD2 human and mouse genes, suggesting 
the presence of binding sites for the transcription factors NF-Кβ, NF-1, C/EBP, AP-1, AP-2 and Sp1 
in the region approximately -500 bp upstream from the transcription start site.  
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7.1.3. Comprehensive SOD2 promoter annotation  
 
The combined results of both singular gene annotations, the PATCH analysis and the manual 
promoter sequence comparisons were used to comprehensively annotate the rat SOD2 gene 
promoter with regards to its putative transcriptionally and epigenetically regulated elements 
(Figure 2). The image clearly illustrates a region beginning approximately -500 bp upstream of 
the transcription start site continuing into the first exon that contains a number of putative 
regulatory sites including binding sites for AP-2 and Sp1. Additionally, it demonstrates that this 
region is located within the promoter CpG island and subsequently has a high GC frequency. The 
putative structure of the rat SOD2 gene promoter shows similarity to that of the human and 
mouse genes. An enlarged version of Figure 2 can be found in appendix A (Figure A2).  
 
 
Figure 2. Comprehensive putative annotation of the rat SOD2 gene promoter region. Each 
annotation is based on more than one source, as indicated by the key. The figure illustrates a 
region of the 5’ promoter and the putative binding sites located within it. The sequence of each 
binding site and its location are shown in relation to the transcription start site, 1+. The GC 
dinucleotides in each sequence are shown in blue font. Binding sites for NF-1, NFКβ and AP-1 
are located -400 to -300 bp of the TSS, while multiple binding sites for AP-2 and Sp1 are 
distributed between -300 and 100+ bp of the TSS. 
 
Each annotation was predicted using the above-mentioned accumulative data. The key provides 
information on the criteria that was used to annotate each binding site. The putative binding sites 
that are labelled with superscripts 1,2,3,4 were predicted by the PATCH analysis, showed 100 % 
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homology to the transcription factor binding site consensus sequence, were located within a 
hypersensitivity-site and showed a similar special arrangement to the homologous human and/or 
mouse SOD2 gene promoter region, respectively.  
 
7.2. RT-PCR REVEALS AN INCREASE IN SOD2 EXPRESSION IN AGING LIVER 
AND A DECREASE IN SOD2 EXPRESSION IN AGING BRAIN 
 
7.2.1. Confirmation of extracted RNA quality 
 
All RNA samples used for cDNA synthesis and subsequently for RT-PCR had a concentration above 
100 ng/µl and 280/260 and 230/260 ratios of between 1.8 and 2.2. Images of RNA samples 
extracted from the liver and brain of 6 rats (3 young and 3 old) obtained through gel 
electrophoresis are shown below (Figure 3). Images were inspected for the presence of two clear 
bands depicting the 28S and 18S RNA, the absence of genomic DNA contamination and significant 
degradation (indicated by smearing). The extracted RNA met all of the above criteria and was 
thus confirmed to be of good quality. 
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Figure 3. Gel electrophoresis images of extracted total RNA. Rats A, C and D were classified as 
“old” while rats B, E and F were “young”. A total of 1 to 3 separate RNA samples were collected 
from the liver or brain tissue of each rat. The GeneRuler 1kb ladder was used with a molecular 
weight range of 250 bp to 10000 bp. A) and B) independently extracted RNA from brain tissue 
of each rat. C) and D) independently extracted RNA from liver tissue of each rat. RNA is 
confirmed to be of good quality due to the presence of two bright 18S and 28S bands and 
absence of smearing and contamination.  
 
7.2.2. Melting curve analysis reveals target specificity for all genes 
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The primer sets used to detect mRNA transcripts for SOD2, CCT4, RAB11B and RPN1 were found 
to be specific for their intended targets. This was indicated by the presence of a single, narrow 
peak. The relative height of each curve indicated that the amplification reactions were efficient. 
Additionally, all four primer sets annealed successfully at 60 ˚C, allowing for the standardization 
of PCR cycling conditions for all RT-PCR experiments run. These features are depicted by the 
melting curves shown in Figures 4 to 7. 
 
 
Figure 4. Melting curve of SOD2, confirming target specificity. The curve illustrates a single, 
sharp peak, indicating the absence of unexpected targets and the successful amplification of 
SOD2 mRNA.  
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Figure 5. Melting curve of CCT4, confirming target specificity. The curve illustrates a single, 
sharp peak, indicating the absence of unexpected targets and the successful amplification of 
CCT4 mRNA.  
 
 
Figure 6. Melting curve of RAB11B, confirming target specificity. The curve illustrates a single, 
sharp peak, indicating the absence of unexpected targets and the successful amplification of 
RAB11B mRNA. 
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Figure 7. Melting curve of RPN1, confirming target specificity. The curve illustrates a single, 
sharp peak, indicating the absence of unexpected targets and the successful amplification of 
RPN1 mRNA. 
 
7.2.3. Standard curve analysis confirms the efficiency, precision and 
sensitivity of RT-PCR gene amplification 
 
The calibration curves generated through a series of RT-PCR reactions allowed for the assessment 
of the efficiency, sensitivity and precision of each gene amplification (Figures 8 to 11). The CP 
data values used to generate each curve are tabulated in appendix B, table B1. These values 
showed consistency (as indicated by the standard error bars) and indicated that the RT-PCR was 
sensitive over an approximate range of 0.01 ng to 100 ng of cDNA. The correlation coefficient 
calculated for each curve was no less than 0.98, where a correlation coefficient of 1 indicates a 
very strong negative correlation between the variables being assessed.  
 
46 
 
 
Figure 8. Standard curve for SOD2. The graph depicts the average CP value for each cDNA 
concentration. The standard curve generated illustrates a strong linear relationship between 
cDNA concentration and CP value (r2 = 0.997) over 5 orders of magnitude. 
 
 
Figure 9. Standard curve for CCT4. The graph depicts the average CP value for each cDNA 
concentration. The standard curve generated illustrates a strong linear relationship between 
cDNA concentration and CP value (r2 = 0.993) over 5 orders of magnitude. 
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Figure 10. Standard curve for RAB11B. The graph depicts the average CP value for each cDNA 
concentration. The standard curve generated illustrates a strong linear relationship between 
cDNA concentration and CP value (r2 = 0.989) over 4 orders of magnitude. 
 
 
Figure 11. Standard curve for RPN1. The graph depicts the average CP value for each cDNA 
concentration. The standard curve generated illustrates a strong linear relationship between 
cDNA concentration and CP value (r2 = 0.984) over 5 orders of magnitude. 
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The efficiency of all gene amplifications fell within the range of 1.8 to 2.2 (Table 1), where an 
efficiency of 2 is deemed ideal. 
 
Table 6. Efficiency of gene amplification. 
Gene Efficiency 
SOD2 1.94 
CCT4 1.93 
RAB11B 2.11 
RPN1 1.97 
 
 
7.2.4. Data normalization reveals a relative increase in SOD2 mRNA 
levels in aging rat liver and a relative decrease in aging rat brain 
 
CP readings were obtained for SOD2 and three reference genes (in triplicate) using cDNA samples 
originating from liver and brain tissue of young and old rats. All raw data readings obtained from 
RT-PCR are tabulated in appendix B, table B2 and B3. All negative controls (both NRTC and NTC) 
showed insignificant levels of fluorescent signalling, showing CP values at least 3 cycles higher 
than the highest experimental value. Figure 12 summarizes the average normalized relative ratios 
of SOD2 mRNA found in young liver compared to old liver tissues. This data suggests that there 
is a relative increase in SOD2 mRNA levels in liver samples of old rats compared to those of young 
rats, however the relative difference in SOD2 mRNA levels between these two groups is not 
significant as illustrated by the standard error bars.  
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Figure 12. RT-PCR reveals increased SOD2 mRNA levels in tissues from old rat liver compared 
to young rat liver. The final average relative ratio in each group is an average of 3 values each 
obtained from a separate biological specimen. Each of these readings is based on CP values 
obtained in triplicate. The data suggests a relative increase in SOD2 mRNA levels in old liver 
tissue compared to young liver tissue, however this is not significant according to the standard 
error calculations.  
 
Figure 13 illustrates the average normalized relative ratios of SOD2 mRNA found in young brain 
compared to old brain tissues. This data suggests that there is a relative decrease in SOD2 mRNA 
levels in brain samples of old rats compared to those of young rats, however the relative 
difference in SOD2 mRNA levels between these two groups is not significant as illustrated by the 
standard error bars. 
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Figure 13. RT-PCR reveals decreased SOD2 mRNA levels in tissues from old rat brain compared 
to young rat brain. The final average relative ratio in each group is an average of 6 values each 
obtained from a separate biological specimen. Each of these readings is based on CP values 
obtained in triplicate. The data suggests a relative decrease in SOD2 mRNA levels in old brain 
tissue compared to young brain tissue, however this is not significant according to the standard 
error calculations.  
 
7.2.5. Statistical analysis reveals that differences in SOD2 mRNA levels 
in young and old rat tissue are insignificant 
 
The t-statistics for relative SOD2 mRNA levels in liver and brain tissues of young and old rats were 
calculated and the P(T<=t) two-tail values were assessed (Tables 5 and 6).  
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Table 7. t-Test for liver RT-PCR data confirms that differences in mRNA levels are statistically 
insignificant. 
  Liver Old 
Liver 
Young  
Mean 1.47 1.16  
Variance 1.01 0.39  
Observations 3.00 3.00  
Pooled Variance 0.70   
Hypothesized Mean 
Difference 0   
df 4.00   
t Stat 0.46   
P(T<=t) one-tail 0.33   
t Critical one-tail 2.13   
P(T<=t) two-tail 0.67   
t Critical two-tail 2.78    
 
 
Table 8. t-Test for brain RT-PCR data confirms that differences in mRNA levels are statistically 
insignificant. 
  Brain Old 
Brain 
Young  
Mean 1.08 1.17  
Variance 0.04 0.11  
Observations 6.00 6.00  
Pooled Variance 0.08   
Hypothesized Mean Difference 0   
df 10.00   
t Stat -0.60   
P(T<=t) one-tail 0.28   
t Critical one-tail 1.81   
P(T<=t) two-tail 0.56   
t Critical two-tail 2.23    
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The P(T<=t) two-tail values for both rat liver and brain RT-PCR data were greater than 0.05, 
confirming that there was no statistically significant difference between the young and old 
groups.  
 
7.3. A METHYLATION ASSAY REVEALS THAT THE RAT SOD2 PROMOTER 
REMAINS LARGELY UNMETHYLATED WITH AGING 
 
7.3.1. Confirmation of extracted DNA quality 
 
All DNA samples used in bisulfite conversion and subsequently for MS-PCR had a concentration 
above 100 ng/µl and 280/260 and 230/260 ratios of between 1.8 and 2.2. Images of DNA samples 
extracted from the brain of 6 rats (3 young and 3 old) obtained through gel electrophoresis are 
shown below (Figure 14). Images were inspected for the presence of a predominant band greater 
than 10000 bp in size depicting intact genomic DNA, the absence of RNA contamination and 
significant degradation (indicated by smearing). The extracted DNA met all of the above criteria 
and was thus confirmed to be of good quality.  
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Figure 14. Gel electrophoresis image of extracted whole genomic DNA. DNA was inspected for 
integrity and purity using gel electrophoresis. Rats A, C and D were classified as “old” while rats 
B, E and F were “young”. The GeneRuler 1kb ladder was used with a molecular weight range of 
250 bp to 10000 bp. DNA is confirmed to be of good quality due to the presence of a DNA band 
greater than 10000 bp in size and the absence of smearing and contamination. 
 
7.3.2. Confirmation of successful bisulfite conversion and Methylation-
specific PCR 
 
Primers designed to target two different regions of the rat SOD2 promoter region were found to 
be specific and successfully amplified each target amplicon (Figure 15). This also confirmed the 
success of bisulfite conversion, as the primers were designed to specifically target bisulfite 
converted DNA only. Each amplicon (region 1A and region 1D) was amplified using bisulfite 
converted DNA originating from the brain tissue of each rat (A to F).  
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Figure 15. Successful MS-PCR amplification using primers for rat SOD2 promoter region 1A and 
1D. The GeneRuler 1kb ladder was used with a molecular weight range of 250 bp to 10000 bp. 
The amplicon 1A is 180 bp in size while the amplicon 1D is 159 bp in size. 
 
7.3.3. Confirmation of successful DNA cloning 
 
Blue/white screening of each streak-plated bacterial transformation partially confirmed the 
success of ligation and transformation of each amplicon. This was further validated by the 
enzyme digestion of each isolated plasmid sample. Gel electrophoresis images of enzyme 
digested recombinant plasmids containing insert 1A and insert 1D can be seen in Figure 16.  
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Figure 16. Enzyme digestions of recombinant plasmid samples indicate successful DNA cloning. 
Plasmids were isolated from two separate colonies. The GeneRuler 1kb ladder was used with 
a molecular weight range of 250 bp to 10000 bp. A) The insertion of amplicon 1A was confirmed 
by the presence of a band at approximately 180 bp. B) The insertion of amplicon 1D was 
confirmed by the presence of a band at approximately 159 bp. 
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7.3.4. Sequencing and analysis reveals that the rat SOD2 promoter 
region remains largely unmethylated with aging 
 
For each amplicon originating from each rat, plasmid DNA from 2 to 3 colonies was sequenced 
and analyzed. The sequences were grouped into two categories, those originating from old brain 
tissue and those originating from young brain tissue. The multiple sequence alignments of each 
group and the unconverted amplicon (1A or 1D) are illustrated in Figures 17 and 18, respectively. 
Enlarged versions of Figure 17 and 18 can be found in appendix A as Figures A3 and A4.  
 
The sequencing results show that in region 1A, 100 % of cytosine residues in both promoter 
regions have been converted into uracil and subsequently thymine, therefore there is 0 % 
methylation in DNA amplicons derived from old and young brain tissues.  
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Figure 17. Multiple sequence alignment of rat SOD2 promoter region 1A and the unconverted 
DNA sequence illustrates that the rat SOD2 promoter remains largely unmethylated in aging 
brain tissue. Converted CpG dinucleotides are highlighted in blue. A) All sequences originate 
from young brain tissue. B) All sequences originate from old brain tissue.  
 
In region 1D isolated from young brain tissue (Figure 18 A) 1 cytosine residue appears to be 
methylated and is located in the 22nd CpG dinucleotide highlighted. This methylation is present 
in 1 out of 7 amplicons sequenced. In region 1D isolated from old brain tissue (Figure 18 B) 1 
cytosine residue appears to be methylated and is located in the 2nd CpG dinucleotide highlighted. 
This methylation is present in 2 out of 8 amplicons sequenced.  
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Figure 18. Multiple sequence alignment of rat SOD2 promoter region 1D and the unconverted 
DNA sequence illustrates that the rat SOD2 promoter remains largely unmethylated in aging 
brain tissue. Converted CpG dinucleotides are highlighted in blue, methylated cytosines are 
highlighted in green. A) All sequences originate from young brain tissue. B) All sequences 
originate from old brain tissue.  
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8. DISCUSSION 
 
8.1. MNSOD ACTIVITY AND REGULATION CHANGES WITH AGING 
 
Manganese superoxide dismutase (MnSOD) has been identified as a critical factor involved in the 
regulation of aging and age-related disease (Warner, 1994; Rosen et al., 1993; Velarde et al., 
2012). In general terms, MnSOD neutralizes toxic superoxide within the mitochondria of the cell, 
thereby preventing downstream oxidative damage to the mitochondrion itself as well as to other 
cellular components (Miao & Clair, 2009). As it functions exclusively in the mitochondria, the 
predominate site of oxygen metabolism and ROS production, it is the most vital of the SOD 
enzymes. This has been demonstrated in transgenic mouse studies where homozygous MnSOD-
deficient mice exhibit neonatal lethality (Huang et al., 1997) and in mice heterozygous for MnSOD 
that are more susceptible to oxidative stress and have reduced mitochondrial function (Kokoszka 
et al., 2001; Velarde et al., 2012). Reduction of mitochondrial capacity and the accumulation of 
oxidative damage in the cells of old mammals are fundamental concepts in the free radical theory 
of aging, however to date, the exact cause of these phenomena has not been conclusively 
elucidated (Alexeyev, Doux & Wilson, 2004; Liochev, 2013). A promising theory in this regard 
posits that major features of the aging phenotype can be attributed to an overall reduction in the 
cell’s antioxidant defenses, more specifically, a reduction in the activity and prevalence of key  
antioxidant enzymes.   
 
Numerous correlation studies in human and rodent models have been performed to investigate 
the activity of major antioxidant enzymes, including MnSOD in the aging context. These studies 
demonstrate that changes in MnSOD activity with aging are highly tissue-specific and the trends 
elucidated are not altogether consistent across studies. (Cand and Verdetti, 1989; Navarro and 
Boveris, 2004; Navarro et al., 2003; Tian, Cai & Wei, 1998). For simplicity, the studies used in this 
comparison are restricted to those investigating MnSOD activity in the brain and liver tissues of 
rodents. Cand and Verdetti (1989) demonstrated an age-related decrease in MnSOD activity in 
liver homogenate of Wistar rats but consistent levels of MnSOD activity in brain homogenate. 
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MnSOD activity was measured through an inhibition assay. Tian, Cai & Wei (1998) also made use 
of an inhibition assay and found no significant change in the activity of MnSOD in brain and liver 
homogenates of Fischer rats with aging, but did find a decrease in MnSOD activity in liver 
mitochondria. Navarro and Boveris (2004) and Navarro et al. (2003) made use of the 
adrenochrome assay and measured MnSOD activity in liver and brain mitochondria and liver and 
brain tissue homogenate of CD-1 mice and Wistar rats, respectively. Their research demonstrated 
a unanimous age-related decrease in MnSOD activity across tissues and rodents. 
 
Discrepancies in the results of these studies may be a result of the different assay methods used, 
strain and ages of rats used and whether MnSOD activity was measured in whole tissue 
homogenate or isolated mitochondria. However, in light of the fact that the most recent 
investigations by Navarro et al. (2003) and Navarro and Boveris (2004) used larger sample groups 
(8 to 20 per group) and found consistent results across mice and rats and in tissue homogenate 
and isolated mitochondria, it can be assumed that these are reliable findings and that MnSOD 
activity may in fact decrease as a function of age in liver and brain tissue. This reduction in enzyme 
activity was paralleled by a number of other enzymes critical for mitochondrial function, including 
mitochondrial nitric oxide synthase, complex I, and complex IV. It was also associated with an 
increased content of oxidation products, thiobarbituric acid-reactive substances and protein 
carbonyls as well as increased mitochondrial fragility, volume and water permeability (Navarro 
& Boveris, 2004). The significant decrease in the activity of critical mitochondrial enzymes and 
overall mitochondrial function and the concurrent increase in oxidative damage demonstrated 
in this study lends validity to the theory that key features of the aging cell may be a result of a 
degenerative antioxidant defense system. 
 
A reduction in overall enzyme activity with aging seen in studies like that of Navarro and Boveris 
(2004) could be affected through a number of possible mechanisms at the transcriptional or 
translation levels. These may include; a) poor maintenance and higher turnover of MnSOD 
protein with aging, b) reduced levels of MnSOD protein synthesis, c) increased turnover of 
MnSOD mRNA, or d) reduced transcription of the MnSOD gene. 
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The turnover of MnSOD mRNA as well as the level of MnSOD protein synthesis could be 
influenced by general mechanisms of post-transcriptional regulation including mRNA processing 
and export as well as microRNA modulation and mRNA binding proteins (Miao & St Clair, 2009). 
Both the basal and stimulus-induced post-transcriptional regulation of MnSOD is determined by 
a ~280-nucleotide fragment located in the mRNA coding region which determines mRNA stability 
(Davis, Monnier & Nick, 2001). Additional post-transcriptional control elements include an Alu-
like element in the MnSOD 3’ untranslated region (UTR) that may be a putative target for 
microRNA (Stuart et al., 2000; Smalheiser & Torvik, 2006) and a redox-sensitive MnSOD RNA-
binding protein that appears to have both positive and negative effects on the translation 
efficiency of MnSOD (Chung, Wright & Clerch, 1998; Knirsch & Clerch, 2000). Although any one 
of these mechanisms could potentially account for a decrease in MnSOD activity with aging, their 
function in the regulation of MnSOD in the aging context has not yet been explored.  
 
At the post-translational level, where the maintenance and turnover of MnSOD protein may 
affect its activity, a number of regulatory mechanisms exist for MnSOD.  A study by Xu et al. 
(2006) investigated the sequence-specific tyrosine nitration of MnSOD in cardiovascular disease 
and aging. Tyrosine nitration is a marker of oxidative stress that can potentially alter the 
biological activity of the modified protein (Xu et al., 2006). Specifically, MnSOD, a protein that is 
nitrated in its active catalytic sites, is rendered inactive by the nitration of a single tyrosine (Xu et 
al., 2006). This research, corroborated by Loo et al. (2000) who also reported nitration and 
inhibition of MnSOD in vascular aging, demonstrated that MnSOD is particularly vulnerable to 
tyrosine-nitration in aging which lead to a reduction in enzymatic activity. Down-regulation of 
MnSOD activity due to what is essentially oxidative damage, suggests that the accumulation of 
oxidative stress in the aging cell is not initially a result of decreased antioxidant function but that 
decreased antioxidant function is actually initiated by oxidative damage. Although this theory is 
plausible, it is still unclear why oxidative damage begins to overwhelm the cell’s formidable 
antioxidant defence system with age.  
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Another post-translational regulatory mechanism that may influence MnSOD activity with aging 
is the reversible acetylation of specific, evolutionarily conserved lysine residues in the MnSOD 
protein (Ozden et al., 2011; Tao et al., 2010). Lysine acetylation has recently emerged as an 
important post-translation modification in the regulation of mitochondrial proteins (Choudhary 
et al., 2009) as several proteomic surveys have revealed significantly high levels of acetylated 
proteins in the mitochondria (Kim et al., 2006). 
 
 Studies by Ozden et al. (2011) and Tao et al. (2010) have investigated the inverse relationship 
between MnSOD activity, MnSOD acetylation and levels of cellular SIRT3 (sirtuin 3) protein. 
Sirtuins are class III histone deactylases that have been implicated in aging and longevity in 
various models (Wood et al., 2004). These enzymes appear to function as fidelity proteins that 
alter the activity of downstream mitochondrial targets in response to oxidative stress 
(Choudhary, 2009). Tao et al. (2010) demonstrates a relationship between MnSOD activity and 
SIRT3, where the absence of SIRT3 in knockout mice leads to increased MnSOD acetylation and 
decreased MnSOD activity while the reintroduction of SIRT3 restores MnSOD activity. 
Additionally both Ozden et al. (2011) and Tao et al. (2010) confirm that SIRT3 interacts with 
MnSOD in vitro. As the sirtuin proteins have been implicated in lifespan and longevity it follows 
that post-translational regulation of MnSOD by SIRT3 may be a mechanism involved in the 
decreased levels of MnSOD seen in aging. This may be due to a down-regulation of SIRT3-
mediated mitochondrial homeostasis as demonstrated by Brown et al. (2013) in hematopoietic 
stem cells.  
 
According to these studies a decrease in SIRT3 regulation would lead to an overall increase in 
MnSOD acetylation and a subsequent decrease in MnSOD activity. Although down-regulation of 
MnSOD through this mechanism is possible, it is unclear what would trigger a progressive down-
regulation in SIRT3 regulation initially. Therefore, it may be of more use to investigate key 
regulators of mitochondrial function in a context where the source of abnormal function can be 
identified.  
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Although the above-mentioned post-transcriptional and post-translational regulatory 
mechanisms are not restricted to MnSOD, they do not account for an overall decrease in the cell’s 
defense against oxidative damage. Numerous proteins are implicated in this process, introducing 
enormous variety in the control elements that govern their eventual fate. It is therefore more 
likely that a generalized trend such as this is a result of a more common cellular mechanism. This 
is suggestive of regulation at the transcriptional level, where all genes are subject to the 
restrictions of chromatin structure.  
 
A generalized mechanism of down-regulation at the level of gene transcription could account for 
the decreased activity seen in a number of antioxidant and mitochondrial enzymes with aging 
(Navarro and Boveris, 2004). As previously described, the activity of critical antioxidant enzymes 
in relation to aging has been assayed in various organisms as well as tissues, however the 
quantification of their specific mRNA species in this context has only been investigated in a 
limited number of studies. To date, work done to elucidate the trend, if any, that MnSOD 
expression shows with aging has proved to be inconsistent. 
  
A study by Rao, Xia and Richardson (1990) investigated the effect of age on the expression of 
several antioxidant enzymes in rat brain, hepatocyte and kidney. This study demonstrated an 
age-related decrease in SOD and catalase mRNA in these tissues that paralleled a decrease in 
enzyme activity with aging. However SOD activity constituted both that for CuZnSOD and MnSOD, 
therefore the specific trend for each enzyme is indistinguishable. The levels of mRNA were 
determined using a dot blot analysis, an outdated technique that has now been surpassed by a 
number of more reliable techniques, including reverse transcription quantitative PCR. Four 
Wistar rats were used for each group, young (4 months) and old (24 months). A more recent 
study by Tsay et al. (2000) focused on the age-associated changes of superoxide dismutase and 
catalase activities in the rat brain. mRNA levels were assayed using a ribonuclease protection 
analysis and were found to be consistent with aging. This study used 3 Wistar rats per group at 
1, 3, 6, 12, 18 and 21 months old.  
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Martin et al. (2002) made use of RT-PCR to investigate the effect of hypoxia/reoxygenation on 
mRNA expression of antioxidant enzymes in rat liver and kidneys. This study found a decrease in 
mRNA expression of all enzymes studied except for MnSOD in aging liver and a progressive 
decrease in all antioxidant enzymes in aged kidney tissue. Each age group, young (6 months) and 
old (22 - 25 months) was made up of 7 to 8 male Wistar rats. 
 
In light of the inconsistent nature of the work performed to investigate a trend in mRNA levels of 
MnSOD and other enzymes in aging to date, it is possible that more reliable and reproducible 
work needs to be completed to this end. This research aimed to quantify and compare levels of 
SOD2 mRNA in extracts from young and old rat brain and liver tissue using the current gold-
standard in mRNA quantification, reverse transcription quantitative PCR.  
 
The current study investigated the SOD2 mRNA levels in brain and liver tissue homogenates of 
young (1 to 2 months) and old (15 to 19 months) Sprague Dawley rats. The RT-PCR results 
demonstrate a slight increase in SOD2 levels in older liver tissue (Figure 12), and a slight decrease 
in SOD2 levels in older brain tissue (Figure 13), however neither of these results are statistically 
significant according to the standard error calculations and t-test analyses (Tables 5 and 6). As a 
result this data can be interpreted in one of two ways; either the lack of a statistically significant 
difference between SOD2 mRNA levels in old and young rat tissues indicates that these mRNA 
levels remain relatively constant with age, or the trends illustrated by the results have some 
biological meaning, but a larger sample size is required to confirm them statistically. If the latter 
argument is considered, results of this study are contrary to that of Tsay et al.  (2000) and 
consistent with that of Martin et al. (2002) who demonstrated consistent SOD2 mRNA levels in 
aging brain and increased SOD2 mRNA levels in aging liver tissue, respectively.  
 
It is important to note that similar to studies assessing MnSOD activity, a number of technical 
considerations could influence the results of correlative study such as this. It appears that large 
variation exists in SOD2 mRNA levels between rats (appendix B, tables B2 and B3). Variation of 
this nature is often observed when many biological replicates are used in an effort to increase 
65 
 
the statistical significance of the results obtained, especially when the experimental differences 
being assessed may be subtle (Bustin et al., 2009). In this case sufficient numbers need to be 
included in order to allow for more subtle experimental differences to be elucidated (Bustin et 
al., 2009). For example, Martin et al. (2002) used up to 8 rats for each age group. 
 
Another consideration is the comparable age groups of the rats classified as either “young” or 
“old”. The majority of studies investigating enzyme activity and or gene expression with aging 
used rats between 4 and 6 months of age in the young group and 21 to 24 months of age in the 
old group, whereas “young rats” included in this study were 1 to 2 months of age and “old” rats 
were 15 to 19 months of age. A study by Tian, Cai and Wei (1998) showed that rats at 1 month 
old showed the lowest activities of total SOD, MnSOD and CuZnSOD in all tissues, which may 
imply that that at this stage, the antioxidant defence system is not yet mature, or the antioxidant 
enzymes have not yet been adequately induced due to a lack of prooxidant exposure. If MnSOD 
levels are in fact significantly lower at this age, this may account for the very subtle decrease and 
actual increase seen in SOD2 mRNA levels of old brain and liver tissue, respectively, as opposed 
to a significant decrease in SOD2 mRNA levels expected for both aging tissues. Additionally, it is 
possible that the “old” rats in this study were not old enough to show significant differences in 
SOD2 mRNA levels compared to young rats. According to the results of Tsay et al. (2000), MnSOD 
levels only begin to decrease after 12 months in age and are lowest at 21 months. This suggests 
that the mRNA levels measured in 15 to 19 month old rats may still have been relatively high 
compared to other older (21 to 24 months) rats.  
 
It is also important to note that MnSOD is susceptible to both basal and induced expression 
(Rogers et al., 2000) and regulation of these different types of expression occurs in different areas 
of the gene. Therefore, even though it would be more useful to ascertain the basal levels of 
MnSOD transcription with aging, we cannot exclude the levels of mRNA that have been induced 
by proinflammatory mediators, which will vary under different conditions. This would naturally 
increase variation between biological samples. Finally, it may be important to consider that the 
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rat brain has been shown to have region-specific antioxidant levels (Tsay et al., 2000) and that 
using unspecified brain regions might contribute to variation in mRNA levels measured.  
 
In light of these considerations, further study would need to be implemented to conclusively 
delineate the pattern of SOD2 expression in the aging context. In order to achieve statistically 
significant results it may be useful to perform a power analysis to determine the number of 
samples necessary. It is also advisable to examine SOD2 mRNA levels at various ages to 
investigate the possibility of a two-part trend (initial MnSOD increase and then subsequent 
decrease later in life) as indicated by Tsay et al. (2000). Finally, it may be beneficial to ensure that 
rats included in the study are in excellent health and do not show any signs of biological variation 
in terms of inflammatory response or overexposure to oxidative stress.  
 
The results of this study indicate that the age-related decrease in MnSOD activity demonstrated 
in studies by Navarro & Boveris (2004) and Navarro et al. (2003) may be a result of transcriptional 
down-regulation of SOD2 in brain tissue of rats. In order to explore potential epigenetic-induced 
down-regulation of the SOD2 gene in aging, this study quantified and compared promoter 
methylation of the SOD2 gene promoter in extracts from young and old rat brain tissue. 
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8.2. EPIGENETIC REGULATION OF MNSOD IN THE AGING CONTEXT 
 
Transcriptional regulation is largely controlled by the transient state of the chromatin structure 
and subsequently by the epigenetic modifications that govern it.  An epigenetic mechanism that 
has long been associated with age-related changes is DNA methylation, where CpG dinucleotides 
predominantly found in CpG islands have demonstrated abnormal patterns of methylation (Klose 
& Bird, 2006). As previously mentioned, the hypermethylation of gene promoters is a repressive 
epigenetic mechanism that has been implicated in cancer as well as aging. Various genes for 
tumour suppression, metabolism and DNA repair have demonstrated abnormal promoter 
methylation (Gentilini, et al., 2012; Winnefeld & Lyko, 2012). In addition to this, more general 
trends of ‘epigenetic drift’ have been revealed in association with aging, cancer and 
neurodegenerative disease, suggesting that this general loss of transcriptional control may be an 
implicative factor in aging and age-related disease (Gentilini, et al., 2012; Winnefeld & Lyko, 2012; 
Herman & Baylin, 2003; Ehrlich, 2002; Wang, Oelze, & Schumacher, 2008). 
 
The MnSOD gene, SOD2, has a large CpG island that spans the promoter and extends into intron 
two (Wan et al., 1994; Ho, Howard & Crapo, 1991; Jones et al., 1995). This GC-rich region contains 
numerous transcriptional binding sites and has been found to be well conserved in human, 
rodents and other mammals. Although the human and mouse SOD2 gene promoter regions are 
well annotated, the rat promoter features are yet to be conclusively delineated. The human SOD2 
gene has multiple binding sites for Sp1 and AP-2 as well as binding sites for NF-1, AP-1, C/EBP and 
NFКβ. The Sp1 and AP-2 binding sequences are found predominantly in the region -500 bp 
upstream to 100+ downstream of the transcription start site (TSS), occur in GC-rich “boxes” and 
are often overlapping (Xu, Porntadavity & St Clair, 2002). The NF-1, AP-1 and NFКβ binding 
sequences are less abundant, with binding sites for NFКβ and AP-1 being located approximately 
-2000 bp and -750 bp upstream of the TSS and binding sites for NFКβ, NF-1 and C/EBP being 
located in a region near the end of intron 2, referred to as the intronic enhancer (Miao & St. Clair, 
2009).  
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The in vivo architecture of the rat SOD2 gene has been investigated using DNAse I- hypersensitive 
site analysis and dimethyl sulfate in vivo footprinting (Kuo et al., 1999). This study revealed 5 
hypersensitive sites within the promoter region and 10 putative constitutive protein-DNA binding 
sites (Kuo et al., 1999). These sites are located in the region approximately -500 bp from the TSS 
and are able to bind Sp1. Additional work by Rodgers et al. (2000) has localized the rat SOD2 gene 
intronic enhancer to a 260 bp fragment in intron 2. This work and other research that refers to 
homologous binding sites in the rat promoter suggests that the rat SOD2 gene is transcriptionally 
regulated in a similar manner to the human gene, however the validity of these sites has not yet 
been confirmed and a comprehensive picture of the regulatory elements at the rat SOD2 
promoter has not yet been established. 
 
In order to address this apparent lack of cumulative information, the transcriptional and 
epigenetic elements in the rat SOD2 promoter were investigated by reviewing information 
obtained from the literature thus far and by providing additional insight through the use of 
appropriate bioinformatics tools. The accumulative data for the USCS/ EpiGenome browser 
annotations, the PATCH analysis as well as other comparisons performed (see methods and 
materials) demonstrates that the rat SOD2 promoter region contains putative binding sites for 
NF-1, NFКβ, AP-1 as well as numerous putative binding sites for the AP-2 and Sp1 transcription 
factors (Figure 2). These sites are concentrated in the region approximately -500 bp to 100+ bp 
of the TSS, with some Sp1 and AP-2 sites overlapping. The binding sequences for Sp1 and AP-2 
are particularly GC-rich and each contain at least one CpG dinucleotide (excluding one Sp1 site). 
The AP-1, NF-1 and NFКβ binding sequences also contain at least one CpG dinucleotide each. This 
illustrates that similar to human and mouse, the rat SOD2 gene may be susceptible to regulation 
by a number of redox-related proteins through the mechanism of DNA-binding. As many of the 
putative transcription factor binding sites in the rat SOD2 promoter are considered to be GC-rich, 
this indicates that the SOD2 gene may be a target of promoter methylation where transcription 
factor binding and therefore transcriptional regulation may become perturbed. 
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Mechanisms of epigenetic regulation in the SOD2 gene have been demonstrated in a number of 
disease and natural models (Archer et al., 2010; Hitchler et al., 2006; Hodge et al., 2005; Huang, 
He & Domann 1999; Thaler et al., 2009). Downregulation of SOD2 has been shown to be 
mediated by hypermethylation of the SOD2 5’ promoter in human multiple myeloma cells (Hodge 
et al., 2005) and human breast cancer cells (Hitchler et al., 2006) while hypermethylation of the 
intronic enhancer showed reduced SOD2 expression in SV40-transformed cells (Huang, He & 
Domann, 1999). 
 
In human multiple myeloma cells hypermethylation was found in a region -191 to 110 of 
transcription start site, in both AP-2 and Sp1 binding sites. Reversal of this aberrant methylation 
with the DNA methyltransferase inhibitor Zebularine restored MnSOD gene expression and 
enzyme levels (Hodge et al., 2005). Similarly, in malignant breast cancer cells analysis of a region 
-1500 to -1100 in relation to the TSS in the SOD2 promoter demonstrated significantly higher 
levels of CpG methylation than their normal cell counterparts and lower SOD2 mRNA levels. The 
causal link between this methylation and SOD2 repression was established when the addition of 
DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine increased MnSOD mRNA and protein 
levels (Hitchler et al., 2006). Hypermethylation of the SOD2 intronic enhancer has been 
demonstrated in pulmonary arterial hypertension (Archer et al., 2010) and in response to diet 
(Thaler et al. 2009) suggesting that promoter methylation may be a widespread mechanism of 
SOD2 regulation. It is important to note that binding of transcriptional regulators at the SOD2 
gene promoter does not always confer gene activation, therefore the functional significance of 
promoter hypermethylation is dependent on the biological context within which the affected 
regions fall.  
 
The two major promoter regions implicated in SOD2 epigenetic regulation are the 5’ basal 
promoter and the intronic enhancer. As discussed, the 5’ basal promoter region is rich in binding 
sites for Sp1 and AP-2 which together seem to constitute the predominant transcription factors 
regulating SOD2 expression (Xu, Porntadavity & St Clair, 2002). Sp1 is an activating transcription 
factor that binds directly to DNA and enhances gene transcription (Briggs et al., 1986). It is 
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essential for both basal and cytokine-induced transcription of SOD2 and requires binding at 
multiple sites. This allows for the formation of a unique loop structure in the 5’ promoter region 
that is necessary for integrated transcription activation of SOD2 (Mastrangelo et al., 1991). While 
Sp1 and the elements of the intronic enhancer all appear to have an activating effect on SOD2 
transcription, AP-2 has been identified as a SOD2 repressor. AP-2 binds directly to its target gene 
and is able to facilitate crosstalk between other transcription factors at the gene promoter (Zhu 
et al., 2001). An immunoprecipitation study and two-hybrid analysis have demonstrated that Sp1 
interacts with AP-2 in vivo and that this interaction plays both a positive and negative role in gene 
transcription (Xu, Porntadavity & St Clair, 2002). An interaction between AP-2 and SP1 is also 
suggested by Sp1 and AP-2’s overlapping binding sites (Xu, Porntadavity & St Clair, 2002). A 
putative AP-1 binding site is also present in the 5’ basal promoter. AP-1 modulates signal 
transduction in cell proliferation and transformation and is also subject to redox regulation (Angel 
& Karin, 1991). Studies have shown an inverse relationship between the levels of SOD2 and AP-1 
in the cell, where MnSOD deficiency enhances AP-1 levels leading to an increase in proliferation 
and apoptosis (Zhao et al., 2002).  
 
The SOD2 intronic enhancer is composed of binding sites for NFКβ, NF-1 and C/EBP and has been 
identified as the most crucial element for cytokine-mediated induction of MnSOD expression 
(Rodgers et al., 2000). A number of studies have established that levels of steady-state MnSOD 
mRNA and protein increase following exposure to bacterial lipopolysaccharide, tumour necrosis 
factor and interleukin-1, suggesting that MnSOD plays a critical role in proinflammatory 
responses (Visner et al., 1990; Visner et al., 1991). 
 
It has been established that the 5’ promoter region of the SOD2 gene contains a number of 
important transcriptional regulatory elements that are GC-rich or contain at least one GC 
dinucleotide, rendering them susceptible to methylation. It has also been demonstrated that 
methylation of these regions can lead to SOD2 down-regulation in various biological contexts. 
However, to date the epigenetic regulation of the rat SOD2 gene has not been investigated in 
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aging. This study addressed this question by assaying a region of the SOD2 promoter for aberrant 
methylation using bisulfite conversion and methylation-specific PCR (MS-PCR).  
The afore-mentioned methylation assay revealed that the rat SOD2 promoter region 
approximately -300 bp upstream to 120+ bp downstream of the transcription start site remains 
largely unmethylated with aging however two aberrantly methylated GC dinucleotide sites were 
detected. The multiple sequence alignment of each group (young and old) and the unconverted 
1A amplicon clearly illustrates that there were no methylated cytosines present in the original 
amplicons of either groups as 100 % of cytosine residues in both promoter regions have been 
converted into uracil and subsequently thymine (Figure 17). The multiple sequence alignment of 
young and old groups and the unconverted 1D amplicon illustrates slightly more variable results 
(Figure 18). While the majority of CpG dinucleotides contain unmethylated cytosine in both 
groups, there are two exceptions. In region 1D isolated from young brain tissue (Figure 18 A) 1 
cytosine residue appears to be methylated and is located in the 22nd CpG dinucleotide 
highlighted. This methylation is present in 1 out of 7 amplicons sequenced. In region 1D isolated 
from old brain tissue (Figure 18 B) 1 cytosine residue appears to be methylated and is located in 
the 2nd CpG dinucleotide highlighted. This methylation is present in 2 out of 8 amplicons 
sequenced. 
 
When mapped to the annotated rat SOD2 promoter sequence these cytosines appear at position 
-40 bp and 85+ bp relative to the TSS. Therefore it can be said that the cytosine at position -40 
bp had a methylation frequency of 14.3 % in amplicons derived from young brain tissue and 0 % 
in amplicons derived from old brain tissue while the cytosine at position 85+ bp had a methylation 
frequency of 25% in amplicons derived from old brain tissue and 0 % in amplicons derived from 
young brain tissue.  
 
As stated, the effect cytosine methylation may have on the overall SOD2 gene expression is highly 
dependent on its regional context. The -40 bp cytosine lies outside of any putative transcriptional 
binding sites, therefore it would be difficult to speculate as to the biological significance it may 
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have without further experimental work. However the 85+ bp cytosine is directly adjacent to a 
Sp1 binding sequence positioned at 78+ bp relative to the TSS (Figure 2). The methylation of this 
cytosine could therefore confer a biologically significant effect by influencing the binding of Sp1 
at this site. In general terms, CpG methylation can sterically hinder potential binding proteins 
thereby preventing their regulatory control (Holliday, 2006). As Sp1 is an activating transcription 
factor for SOD2, prevention of its binding would have a negative effect on SOD2 expression. 
Additionally, the presence of CpG methylation allows a DNA sequence to be targeted by various 
methyl-binding domain proteins which can go on to recruit and interact with histone deactylases 
(HDACs) and histone methyltransferases (HMTs). This integrated response to DNA methylation 
can result in the formation of repressive chromatin structures that ultimately lead to decreased 
gene expression (Holliday, 2006).  
 
In saying this, gene silencing as a result of DNA methylation is more commonly a result of 
hypermethylation across the promoter region and not methylation of a single site. Epigenetic 
downregulation of SOD2 was attributed to CpG hypermethylation detected across eight CpG sites 
in human breast cancer cells (Hitchler et al., 2006) and across 10 CpG sites in human multiple 
myeloma cells (Hodge et al., 2005). However, contrary to this, in a study investigating the 
epigenetic changes in SOD2 in pulmonary arterial hypertension, differential hypermethylation 
was detected in one CpG site only in the SOD2 intronic enhancer region, and demethylation of 
this site with 5-AZA treatment increased SOD2 mRNA and protein in a dose-dependent manner 
(Archer et al., 2010). Therefore it is clear that the effect individual CpG methylation sites may 
have on overall SOD2 expression is dependent on their location and biological context.  
 
The methylation assay performed for the region -300 bp to 120+ bp of the rat SOD2 promoter 
only detected 2 differentially methylated sites out of a total of 46 CpG dincleotides present in 
this region. This suggests that the promoter region remains largely unmethylated with aging. 
Although the 85+ bp cytosine is located adjacent to a Sp1 binding site, the presence of numerous 
other unmethylated Sp1 binding sites in the promoter is likely to render the effect of a single 
methylated cytosine insignificant.  
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The importance of individual Sp1 binding sites has been assessed in the human SOD2 promoter. 
Systematic deletion analysis as well as site-specific mutagenesis analysis performed by Xu, 
Porntadavity & Clair (2002) revealed that a fragment -555 to 24+ bp in the promoter region, 
containing clusters of Sp1 and AP-2 sites, was sufficient for high-level transcription of the reporter 
gene. Within this region, at least two binding motifs were needed to achieve minimal 
transcriptional activity and all binding motifs were required to achieve high levels of 
transcriptional activity (Xu, Porntadavity & Clair, 2002). Although the rat and human SOD2 
promoter regions are not identical in their structure and relative locations of Sp1 binding sites, it 
is likely that the Sp1 site detected at 78+ bp, adjacent to the 85+ bp differentially methylated 
cytosine, falls outside of this critical region, as it would on the human gene. Therefore it is unclear 
whether methylation at this site would confer any significant influence on overall SOD2 
expression. However in order to conclusively eliminate epigenetic regulation as an underlying 
cause for aberrant SOD2 expression and MnSOD activity in aging, further work would need to be 
undertaken.  
 
This could entail a reproduction of the methylation assay performed in this study, however on a 
broader scope. This study assessed 2 to 3 clones representing each promoter region (1A and 1D 
covering a region -300 bp to 120+ bp relative to the TSS) from each rat, where 3 rats were used 
per age group (young and old). If the sample size and the number of clones per DNA fragment 
were increased it may be possible to confirm whether the aberrant methylation observed in 
region 1D originating from old rats has a significant increase in frequency compared to those of 
young rats or if these observations were simply anomalies.  
 
Additionally, it would be of use to confirm whether methylation in this specific region would have 
a significant impact on overall SOD2 expression. This could be explored using transfection studies 
and methylated SOD2-CAT promoter-reporter constructs similar to those used by Huang et al. 
(1996). This experiment demonstrated that methylation of specific cytosines in the SOD2 5’ 
flanking region is sufficient to repress transcriptional activity of the SOD2 promoter by at least 50 
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%. Another consideration would be the investigation of methylation content in other significant 
regulatory regions in the rat SOD2 promoter, such as the intronic enhancer region, that has been 
shown to be epigenetically regulated in age-related diseases (Huang, He & Domann, 1999; Archer 
et al., 2010). It is possible that although limited methylation was detected in the SOD2 5’ 
promoter region in this study, age-related methylation may occur in the enhancer region found 
in intron 2. This would affect the capacity for SOD2 to respond to cytokine-mediated induction 
of gene expression as opposed to basal levels of gene expression.  
 
8.3. CONCLUSION  
 
MnSOD is a vital antioxidant enzyme that has been shown to decrease in activity with aging. The 
biological mechanism underlying this down-regulation has not yet been elucidated. An RT-PCR 
analysis of SOD2 mRNA levels in old rat tissues compared to young rat tissues revealed a subtle 
increase and decrease of mRNA in old liver and brain tissue respectively, however these results 
were not proved to be statistically significant. This data may indicate that the reduced activity of 
MnSOD seen in aging is a result of regulation at a post-transcriptional level or that the subtle 
changes seen in SOD2 mRNA levels in aging rat tissue may have biological significance, but a 
larger sample size is required to validate these trends statistically. Based on this assumption and 
the knowledge that the SOD2 gene is susceptible to epigenetic regulation in various age-related 
disease models, epigenetic regulation of the SOD2 gene promoter in an age-related context was 
investigated with a methylation assay. While 2 aberrantly methylated cytosine residues were 
detected in the rat SOD2 5’ promoter region, the majority of the promoter DNA assessed 
remained unmethylated with aging. This suggests that a reduction in SOD2 levels in aging brain 
tissue is unlikely to be a result of aberrant epigenetic regulation. In order to further explore 
epigenetic modification of the SOD2 gene promoter with aging, it may be useful to reproduce the 
methylation assay performed in this study on a larger scale with regard to the sample size, the 
number of clones assessed and the regions of the SOD2 promoter investigated.  
  
75 
 
9. REFERENCES 
 
Alexeyev, M. F., Doux, S.P.L.E. and Wilson, G. L. (2004). Mitochondrial DNA and aging. Clinical 
Science, 364, 355-364. 
 
Angel, P., and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation 
and transformation. Biochimica Biophysica Acta, 1072, 129-157. 
 
Aquila, P. D., Rose, G., Bellizzi, D., and Passarino, G. (2012). Epigenetics and Aging. Maturitas, 1-
7.   
 
Archer, S.L., Marsboom, G., Kim, G.H., Zhang, H.J., Toth, P.T. Svensson, E.C., Dyck, J.R.B., 
Gomberg-Maitland, M., Thebaud, B., Hsain, A.N., Cipriani, N. and Rehman, J. (2010). Epigenetic 
attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a 
basis for excessive cell proliferation and a new therapeutic target. Circulation, 121, 2661-2671.  
 
Balaban, R.S., Nemoto, S. and Finkel. (2005). Mitochondria, oxidants and aging. Cell, 120, 483-
495. 
 
Barja, G. (2013). Updating the nitochondrial free radical theory of aging: an integrated view, key 
aspects, and confounding concepts. Antioxidants & Redox Signalling, 19(12), 1420-1445.  
 
Bette, M., Schlimme, S., Mutters, R., Menendez, S., Hoffman, S. and Schulz, S. (2004). Influence 
of different anaesthetics on pro-inflammatory cytokine expression in rat spleen. Laboratory 
Animals, 38, 272-279. 
 
Briggs, M.R., Kadonaga, J.T., Bell, S.P. and Tjian, R. (1986). Purification and biochemical 
characterization of the promoter-specific transcription factor, Sp1. Science, 234, 47-52. 
 
Brown, K., Xie, S., XIAOlei, Q., Mohrin, M., Shin, J., Liu, Y., Zhang, D., Scadden, D.T. and Chen, D. 
(2013). SIRT3 reverses aging-associated degeneration. Cell Reports, 3(2), 319-327. 
 
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., 
Pfaffl, M.W., Shipley, G.L., Vandesompele, J. and Wittwer, C.T. (2009). The MIQE guidelines: 
minimum information for publication of quantitative real-time PCR experiments. Clinical 
Chemistry, 55(4), 1-12.  
 
Butterfield, D.A., Castegna, A., Lauderback, C.M. and Drake, J. (2002). Evidence that amyloid 
beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain 
contribute to neuronal death. Neurobiology and Aging, 23, 655-664. 
 
76 
 
Cand, F. and Verdetti, J. (1989). Superoxide dismutase, glutathione peroxidase, catalase, and 
lipid peroxidation in the major organs of the aging rats. Free Radical Biology & Medicine, 7, 59-
63. 
 
Choudhary, C., Kumar, C., Gnad, F., Nielson, M.L., Rehman, M., Walther, T.C., Olsen, J.V. and 
Mann, M. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular 
functions. Science, 325, 834-840.  
 
Chung, D.J., Wright, A.E. and Clerch, L.B. (1998). The 3’ untranslated region of manganese 
superoxide dismutase RNA contains a translational enhancer element. Biochemistry, 37, 16298-
16306. 
 
Davis, C.A., Monnier, J.M. and Nick, H.S. (2001).  A coding region determinant of instability 
regulates levels of manganese superoxide dismutase mRNA. The Journal of Biological 
Chemistry, 276, 37317-37326. 
 
DeAngelis, J.S. and Farrington, W.J. (2008). An overview of epigenetic assays. Molecular 
Biotechnology, 38(2), 179-183. 
 
Dioum, E.M., Chen, R., Alexander, M.S., Zhang, Q., Hogg, R.T., Gerard, R.D. and Garda, J.A. 
(2009). Regulation of hypoxia-inducible factor 2α signaling by the stress-responsive deacetylase 
sirtuin 1. Science, 324, 1289-1293.  
 
Ehrlich, M. (2002). DNA methylation in cancer: too much, but also too little. Oncogene, 21, 
5400-5413. 
 
Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.-Q., Bien-Ly, N. and Mucke, L. (2006). 
Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology 
and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic 
mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 26(19), 
5167-5179.  
 
Flint, D.H. et al. (1993). The inactivation of Fe-S cluster containing hydrolases by superoxide. 
The Journal of Biological Chemistry, 268, 22369-22376. 
 
Gentilini, D., Mari, D., Castaldi, D., et al. (2012). Role of epigenetics in human aging and 
longevity: genome-wide DNA methylation profile in centenarians and centenarians’ offspring. 
Age, 35(5), 1961-1973. 
 
Gupta, R.K., Patel, A.K., Shah, N., Chaudhary, A.K., Jha, U.K., Yadav, U.C., Gupta, P.K. and 
Pakuwal, U. (2014). Oxidative stress and antioxidants in disease and cancer: a review. Asian 
Pacific Journal of Cancer Prevention, 15(11), 4405-4409. 
 
77 
 
Harman, D. (1957). Ageing: a theory based on free radical and radiation chemistry. The Journal 
of Gerontology, 2, 298-300. 
 
Harman, D. (2006). Free radical theory of aging: an update: increasing the functional life span. 
Annals of the New York Academy of Sciences, 1067, 10-21.  
 
Herman, J.G. and Baylin, S.B. (2003). Gene silencing in cancer in association with promoter 
hypermethylation. New England Journal of Medicine, 349, 2042-2054. 
Hitchler, M., Wikainapakul, K., Yu, L. Powers, K., Attatippaholkun, W. and Domann, F.E. (2006). 
Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer 
cells. Epigenetics, 1(4), 163-171. 
 
Ho, Y.S., Howard, A.J. and Crapo, J.D. (1991). Molecular structure of a functional rat gene for 
manganese-containing superoxide dismutase. American Journal of Respiratory Cell and 
Molecular Biology, 4, 278-286.  
 
Hodge, D.R., Peng, B., Pompeia, C., Thomas, S., Cho, E., Clausen, P.A., Marquez, V.E. and Farrar, 
W.L. (2005). Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 
human multiple myeloma cells increases cell proliferation. Cancer Biology & Therapy, 4(5), 585-
592.  
 
Holliday, R. (2006). Epigenetics: A Historical Overview. Epigenetics, 1(2), 76-80. 
 
Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991). p53 mutations in human 
cancers. Science, 253, 49-53.  
 
Huang, Y., He, T., and Domann, F. E. (1999). Decreased expression of manganese superoxide 
dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 
gene. DNA and Cell Biology, 18(8), 643-652.  
 
Huang, Y., Peng, J., Oberley, L.W. and Domann, F.E. (1996). Transcriptional inhibition of 
manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5’ CpG 
island. Free Radical Biology & Medicine, 23(2), 314-320.  
 
Huang, T., Yasunami, M., Carlson, E.J., Gillespie, A.M., Reaume, A.G., Hoffman, E.K., Chan, P.H., 
Scott, R.W. and Epstein, C.J. (1997). Superoxide-mediated cytotoxicity in superoxide dismutase-
deficient fetal fibroblasts. Archives of Biochemistry and Biophysics, 344(2), 424-432.  
 
Hulbert, A.J., Pamplona, R., Buffenstein, R. and Buttemer, W.A. (2007). Life and Death: 
Metabolic rate, membrane composition and life span of animals. Physiological Reviews, 87(4), 
1175-1213. 
 
78 
 
Illingworth, R.S. and Bird, A.P. (2009). CpG islands–‘a rough guide.’ FEBS Letters, 583, 1713-
1720. 
 
Ischiropoulos, H. and Beckman, J. S. (2003). Oxidative stress and nitration in 
neurodegeneration : Cause, effect, or association? Neurodegeneration, 111(2), 163-169.  
 
Jones, P.L., Kucera, G., Gordon, H. and Boss, J.M. (1995). Cloning and characterization of the 
murine manganous superoxide dismutase-encoding gene. Gene, 153, 155-161. 
 
Jones, P.A. and Baylin, S.B. (2007). The Epigenomics of Cancer. Cell, 128, 683-692. 
 
Jintaridth, P. and Mutirangura, A. (2010). Distinctive patterns of age-dependent 
hypomethylation in interspersed repetitive sequences. Physiological Genomics, 41, 194-200.  
 
Keller, J. N., Kindy, M. S., Holtsberg, F. W., Clair, D. K. S., Yen, H., Germeyer, A. and Mattson, M. 
P. (1998). Apoptosis and Reduces Ischemic Brain Injury: Suppression of Peroxynitrite 
Production, Lipid Peroxidation, and Mitochondrial Dysfunction. The Journal of Neuroscience : 
The Official Journal of the Society for Neuroscience, 18(2), 687-697. 
 
Kim, S.C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, L., Grishin, N.V., 
White, M., Yang, X.J. and Zhao, Y. (2006). Substrate and functional diversity of lysine acetylation 
revealed by a proteomics survey. Molecular cell, 23, 607-618. 
 
Kirkinezos, I. G. and Moraes, C. T. (2001). Reactive oxygen species and mitochondrial diseases. 
Seminars in Cell & Developmental Biology, 12(6), 449-457.  
 
Klose, R.J. and Bird, A.P. (2006). Genomic DNA methylation: the mark and its mediators. Trends 
in Biochemical Sciences, 31, 89-97. 
 
Knirsch, L. and Clerch, L.B. (2000). A region in the 3’ UTR of MnSOD RNA enhances translation of 
a heterologous RNA. Biochemical and Biophysical Research Communications, 272, 164-168. 
 
Kuo, S., Chesrown, S. E., Mellott, J.K., Rodgers, R.J., Hsu, J. and Nick, H.S. (1999). In vivo 
architecture of the manganese superoxide dismutase promoter. The Journal of Biological 
Chemistry, 274(6), 3345-3354. 
 
Kokoszka, J.E., Coskun, P., Esposito, L.A. and Wallace, D.C. (2000). Increased mitochondrial 
oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial 
function culminating in increased apoptosis. PNAS, 98(5), 2278-2283.  
 
Lee, J., Koo, N., & Min, D. B. (2004). Species, Aging, and Antioxidative Nutraceuticals. 
Comprehensive Reviews in Food Science and Food Safety, 3, 21-33. 
 
79 
 
Liochev, S.I. (2013). Reactive oxygen species and the free radical theory of aging. Free Radical 
Biology and Medicine, 60, 1-4.  
 
Lin, S., Kaeberlein, M., Andalis, A.A., Sturtz, L.A., Defossez, P., Culotta, V.C., Fink, G.R. and 
Guarente, L. (2002). Clorie restriction extends Saccharomyces cerevisiae life span by increasing 
respiration. Nature, 418, 344-348.  
 
Loft, S. and Poulsen, H.E. (1996). Cancer risk and oxidative DNA damage in man. Journal of 
Molecular Medicine, 74, 297-312.  
 
Loo, B., Labugger, R., Skepper, J.N., Bachschmid, M., Kilo, J., Powell, J.M., Palacious-Callender, 
M., Erusalimsky, J.D., Quaschning, T., Malinski, T., Gygi, D., Ulrich, V and Luscher, T.F. (2000). 
Enhanced peroxynitrate formation is associated with vascular aging. Journal of Experimental 
medicine, 192(12), 1731-1743.  
 
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J.A. and Freedman, 
M. L. (1998). Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s 
disease. Experimental Neurology, 150(1), 40-44.  
 
Martin, R., Fitzl, G., Mozet, C., Martin, H., Welt, K. and Wieland, E. (2002). Effect of age and 
hypoxia/reoxygenation on mRNA expression of antioxidant enzymes in rat liver and kidneys. 
Experimental Gerontology, 37, 1479-1485.  
 
Mastrangelo, I.A., Courey, A.J., Wall, J.S., Jackson, S.P. and Hough, P.V. (1991). DNA looping and 
Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. PNAS USA, 
88, 5670-5674. 
 
Matés, J. M. (2000). Effects of antioxidant enzymes in the molecular control of reactive oxygen 
species toxicology. Toxicology, 153(1-3), 83-104.  
 
Matés, J. M., Segura, J.A., Alonso, F.J., Márquez, J. (2012). Oxidative stress in apoptosis and 
cancer: an update. Archives of Toxicology, 86(11), 1649-1665.  
 
Miao, L. and Clair, D. S. (2009). Regulation of superoxide dismutase genes: implications in 
disease. Free Radical Biology and Medicine, 47(4), 344-356.  
 
Navarro, A. and Boveris, A. (2004). Rat brain and liver mitochondria develop oxidative and lose 
enzymatic activities on aging. The American Journal of Physiology. Regulatory, Integrative and 
Comparative Physiology, 287, R1244-R1249. 
 
Navarro, A., Gomez, C., Lopez-Cepero, J.M. and Boveris, A. (2003). Beneficial effects of 
moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial 
80 
 
electron transfer. The American Journal of Physiology. Regulatory, Integrative and Comparative 
Physiology, 286, R505-R511. 
 
Ozden, O., Park, S., Kim, H. Jiang, H., Coleman, M.C., Spitz, D.R. and Gius, D. (2011). Acetylation 
of MnSOD directs enzymatic activity responding to cellular status or oxidative stress. Aging, 
3(2), 102-107.  
 
Rai, P. and Troen, B.R. (2011). Cell and molecular aging. Principles and Practice of Geriatric 
Surgery, 5-37.  
 
Rao, G., Xia, E. and Richardson, A. (1990). Effect of age on the expression of antioxidant 
enzymes in male Fischer F344 rats. Mechanisms of Ageing and Development, 53, 49-60.  
 
Rattan, S. I. S. (2006). Theories of biological aging: genes, proteins, and free radicals. Free 
Radical Research, 40(12), 1230-1238.  
 
Reddy, P. (2009). The role of mitochondria in neurodegenerative diseases: mitochondria as a 
therapeutic target in Alzheimer’s disease. CNS Spectrums, 14, 8-18.  
 
Richardson, B. (2003). Impact of aging on DNA methylation. Ageing Research Reviews, 2, 194-
200.  
 
Rodgers, R.J., Chesrown, S.E., Kuo, S., Monnier, J.M. and Nick, H.S. (2000). Cytokine-inducible 
enhancer with promoter activity in both the rat and human manganese-superoxide dismutase 
genes. Biochemistry Journal, 347, 233-242. 
 
Rosen, D.R., Siddique, T., Patterson, D., et al (1993). Mutations in Cu/Zn superoxide dismutase 
gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.  
 
Soo You, J., Jones, P.A. (2012). Cancer genetics and epigenetics: Two sides of the same coin? 
Cancer Cell, 22(1), 9-20.  
 
Smalheiser, N.R. and Torvik, V.I. (2006). Alu elements within human mRNAs are probable 
microRNA targets. Trends in Genetics, 22, 532-536. 
 
Stuart, J.J., Egry, L.A., Wong, G.H. and Kaspar, R.L. (2000). The 3’ UTR of human MnSOD mRNA 
hybridizes to a small cytoplasmic RNA and inhibits gene expression. Biochemical and Biophysical 
Research Communications, 274, 641-648.  
 
Sutherland, G.T., Chami, B., Youssef, P. and Witting, P.K. (2013). Oxidative stress in Alzheimer’s 
disease: Primary villain or physiological by-product? Redox Report, 18(4), 134-141.  
 
81 
 
Taby, R. and Issa, J.J. (2010). Cancer Epigenetics. CA: A Cancer Journal for Clinicians, 60, 376-
392. 
 
Tao, R., Coleman, M.C., Pennington, D., Ozden, O., Park, S., Jiang, H., Kim, H., Flynn, C., Hill, S., 
McDonald, W.H., Olivier, A.K. and Spitz, D.R. (2010). Sirt3-mediated deactylation of 
evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Molecular 
Cell, 40, 893-904.  
 
Thaler, R., Karlic, H., Rust, P. and Haslberger, A.G. (2008). Epigenetic regulation of human buccal 
mucosa mitochondrial superoxide dismutase gene expression by diet. British Journal of 
Nutrition, 101, 743-749. 
 
Tian, L., Cai, Q. and Wei, H. (1998). Alterations of antioxidant enzymes and oxidative damage to 
macromolecules in different organs of rats during aging. Free Radical Biology & Medicine, 24(9), 
1477-1484.  
 
Toyota, M., & Issa, J. P. (1999). CpG island methylator phenotypes in aging and cancer. Seminars 
in Cancer Biology, 9(5), 349-357. 
 
Tsai, H. and Baylin, S.B. (2011). Cancer epigenetics: linking basic biology to clinical medicine. Cell 
Research, 21, 502-517. 
 
Tsay, H., Wang, P., Wang, S. and Ku, H. Age-associated changes of superoxide dismutase and 
catalase activities in the rat brain. Journal of Biomedical Sciences, 7, 466-474.  
 
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007). Free radicals 
and antioxidants in normal physiological functions and human disease. The International 
Journal of Biochemistry & Cell Biology, 39(1), 44-84.  
 
Velarde, M.C., Flynn, J.M., Day, N.U., Melov, S. and Campisi, J. (2012). Mitochondrial oxidative 
stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the 
skin. Aging, 4(1), 3-12.  
 
Visner, G.A., Block, E.R., Burr, I.A. and Nick, H.S. (1991). Regulation of manganese superoxide 
dismutase in porcine pulmonary artery endothelial cells. American Journal of Physiology, 
260(6), L444-L449. 
 
Visner, G.A., Dougall, W.C., Wilson, J.M., Burr, I.A. and Nick, H.S. (1990). Regulation of 
manganese superoxide dismutase by lipopolysaccharide, Interleukin-1 and Tumour Necrosis 
Factor. The Journal of Biological Chemistry, 265(5), 2856-2864. 
 
Vlaming, H. and van Leeuwen, F. (2012). Crosstalk between aging and the epigenome. 
Epigenomics, 4, 5-7. 
82 
 
 
Waki, T., Tamura, G., Sato, M., & Motoyama, T. (2003). Age-related methylation of tumor 
suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene, 22(26), 4128-
4133. 
 
Wan, X.S., Devalaraja, M.N. and St Clair, D.K. (1994). Molecular structure and organization of 
the human manganese superoxide dismutase gene. DNA and Cell Biology, 13, 1127 – 1136. 
 
Wang, S.C., Oelze, B. and Schumacher, (2008). Age-specific epigenetic drift in late-onset 
Alzheimer’s disease. PLoS ONE, 3, 2698-2871. 
 
Waris, G. and Ahsan, H. (2006). Reactive oxygen species: role in the development of cancer and 
various chronic conditions. Journal of Carcinogenesis, 5, 14-21. 
 
Warner, H.R. (1994). Superoxide dismutase, aging and degenerative disease. Free Radical 
Biology and Medicine, 17(3), 249-258. 
 
Wickens, A. P. (2001). Ageing and the free radical theory. Respiration Physiology, 128, 379-391. 
 
Winnefeld, M. and Lyko, S. (2012). The aging epigenome: DNA methylation from the cradle to 
the grave. Genome Biology, 13, 156. 
 
Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M. and Sinclair, D. (2004). Sirtuin 
activators mimic caloric restriction and delay ageing in metazoans. Nature, 430, 686-689.  
 
Xu, S., Ying, J., Jlang, B., Guo, W., Adachi, T., Sharov, V., Lazar, H., Menzolan, J., Knyushko, V., 
Bigelow, D., Schonelch, C. and Cohen, R.A. (2006). Detection of sequence-specific tyrosine 
nitration of manganese SOD and SERCA in cardiovascular disease and aging. American Journal 
of Physiology, 290, H2220-H2227.  
 
Xu, Y., Porntadavity, S. and St Clair, D.K. (2002). Transcriptional regulation of the human 
manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating 
protein-2 (AP-2). Biochemistry Journal, 362, 401-412. 
 
Yen, T., King, K., Lee, H., Yeh, S. and Wei, Y. (1994). Age-dependent increase of mitochondrial 
DNA deletions together with lipid peroxides and superoxide dismutase in human liver 
mitochondria. Free Radical Biology & Medicine, 16(2), 207-214. 
  
Zawia, N., Lahiri, D. and Cardozo-Pelaez, F. (2009). Epigenetics, oxidative stress, and Alzheimer 
disease. Free Radical Biology, 46(9), 1241-1249.  
 
Zhao, Y., Oberley, T.D., Chaiswing, L., Lin, S.M., Epstein, C.J., Huang, T.T. and St. Clair, D. (2002). 
Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-
83 
 
induced atlerations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene, 21, 
3836-3846. 
 
Zhu, C., Huang, Y., Oberley, L.W. and Domann, F.E. (2001). A family of AP-2 proteins down-
regulate manganese superoxide dismutase expression. The Journal of Biological Chemistry, 
276(17), 14407-14413. 
 
  
84 
 
10. APPENDICES 
10.1. Appendix A 
 
All agarose gel used in gel electrophoresis was prepared as follows: 
5 g Agarose gel 
50 ml distilled water 
5 µl GRGreen nucleic acid stain 
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10.3. Appendix C 
 
Table B1. CP data values used to generate standard curves. 
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Table B2. Raw data readings obtained from RT-PCR using liver tissue. 
Liver   RAT A RAT C RAT D RAT B RAT E RAT F 
SOD2 1 20.21 22.70 22.03 20.30 21.88 21.00 
  2 19.83 22.92 21.27 20.23 21.32 21.16 
  3 19.83 22.91 21.65 20.43 21.80 21.27 
  Mean 19.96 22.84 21.65 20.32 21.67 21.14 
  SD 0.18 0.10 0.31 0.08 0.25 0.11 
  SE 0.10 0.06 0.18 0.05 0.14 0.06 
  NRTC 0.00 0.00 33.30 0.00 0.00 30.74 
  NTC 0.00 0.00 31.99 35.00 34.50 35.00 
CCT4 1 21.13 24.53 22.04 21.15 21.88 21.96 
  2 21.77 24.30 22.06 21.10 21.62 21.96 
  3 21.90 24.52 22.10 21.56 21.91 21.90 
  Mean 21.60 24.45 22.07 21.27 21.80 21.94 
  SD 0.34 0.11 0.02 0.21 0.13 0.03 
  SE 0.19 0.06 0.01 0.12 0.08 0.02 
  NRTC 0.00 32.36 33.32 0.00 35.00 35.00 
  NTC 0.00 32.79 0.00 0.00 35.00 35.00 
RAB11B 1 24.25 23.10 25.73 24.31 24.63 23.77 
  2 24.34 23.08 25.81 24.47 24.94 23.76 
  3 24.29 23.23 25.90 24.95 24.82 23.80 
  Mean 24.29 23.14 25.81 24.58 24.80 23.78 
  SD 0.04 0.07 0.07 0.27 0.13 0.02 
  SE 0.02 0.04 0.04 0.16 0.07 0.01 
  NRTC 0.00 31.73 33.18 0.00 32.15 33.17 
  NTC 0.00 32.30 0.00 0.00 35.00 0.00 
RPN1 1 22.74 21.92 23.35 22.60 22.67 22.23 
  2 22.52 21.63 23.26 22.32 22.52 22.36 
  3 22.62 22.09 23.44 22.45 22.87 22.32 
  Mean 22.63 21.88 23.35 22.46 22.69 22.30 
  SD 0.09 0.19 0.07 0.11 0.14 0.05 
  SE 0.01 0.03 0.01 0.02 0.02 0.01 
  NRTC 0.00 0.00 35.00 0.00 35.00 0.00 
  NTC 0.00 0.00 35.00 0.00 35.00 0.00 
        
 Normalised 
ratio  
2.464316 0.452794 1.500661 1.842415 0.628313 1 
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